Ï㽶ÊÓƵ

Miklos Z. Molnar
( out of 64 reviews )

Miklos Z. Molnar, MD, PhD

Languages spoken: English, Hungarian

Clinical Locations

Helena Specialty Clinic at St. Peter's Health

Helena
801-581-2634

Reno U of U Health Specialty Clinic at Carson Tahoe Medical Group

Reno
801-581-2634

Boise Specialty Clinic at St. Luke's Meridian Medical Center

Boise Specialty Clinic
Meridian
801-581-2634

Transplant Center

Transplant Center
Salt Lake City
801-581-2634

  • Dr. Miklos Z. Molnar is a Professor of Medicine and the Medical Director of the Kidney and Pancreas Transplantation Programs and Living Donor Transplantation Program at the Ï㽶ÊÓƵ of Utah Hospital and Clinics and the Director of the Kidney Clinics. Dr. Molnar obtained his M. D. and Ph. D. from Semmelweis Ï㽶ÊÓƵ, Budapest, Hungary. He completed his residency and fellowship in Europe then immigrated to USA in 2010. Dr. Molnar completed residency in Internal Medicine and received additional specialized training and faculty experience as a transplant nephrologist at Ï㽶ÊÓƵ of Tennessee Health Science Center, Memphis, TN after he completed his North American nephrology fellowship training at Ï㽶ÊÓƵ of Toronto, Ontario, Canada. Dr. Molnar is board certified in Internal Medicine and Nephrology. Dr. Molnar is also board certified in Internal Medicine, Nephrology and Transplant Medicine in Europe. His primary clinical interests involve all aspects of kidney transplantation including candidate evaluation for recipients and living donors, processes of care around organ procurement and quality assessment, and perioperative as well as long-term care of recipients and their donors. In addition, Dr. Molnar’s clinical interests include the medical evaluation and care of pancreas transplant recipients as well as the prevention, diagnosis and treatment of various native kidney diseases and acute kidney injury. Dr. Molnar’s primary research interests involve outcome research in kidney transplant recipients. Dr. Molnar is active in clinical research and frequently gives talks in national and international meetings. Dr. Molnar is a primary, senior author or co-author of more than 300 articles in the field of nephrology and transplant medicine. He serves as an Editorial board member for several journals.

    Languages spoken: English, Hungarian

    Specialties

    Board Certification

    American Board of Internal Medicine (Internal Medicine)
    American Board of Internal Medicine (Sub: Nephrology)
    Educational Commission for Foreign Medical Graduates
    European Board of Internal Medicine (EBIM)
    European Board of Transplant Medicine (EBTM)
    National Board of Medical Examiners

    Patient Rating

    4.9 /5
    ( out of 64 reviews )

    The patient rating score is an average of all responses on our patient experience survey. The rating averages scores for all questions about care from our providers.

    The scale on which responses are measured is 1 to 5 with 5 being the best score.

    Patient Comments

    Patient comments are gathered from our patient experience survey and displayed in their entirety.
    Patients are de-identified for confidentiality and patient privacy.

    October 14, 2024
    EXTERNAL SITE

    Unpretentious, very personable, and made the patient feel like an equal part of the team, while simultaneously projecting a superior knowledge of his field. He made me feel confident in his ability.

    October 10, 2024
    UH HOSPITALS AND CLINICS

    Miklos Z Milner was very informational. He read my chart (400) pages and he knew everything about me. I was extremely happy with Him.

    September 28, 2024
    EXTERNAL SITE

    Dr Molnar is awesome very knowledgeable. Dr Molnar gives me a very positive outlook

    July 14, 2024
    UH HOSPITALS AND CLINICS

    Very good explaining labs,medications,and care.

    July 13, 2024
    UH HOSPITALS AND CLINICS

    I had personal questions that were handled with gracious care.

    July 12, 2024
    UH HOSPITALS AND CLINICS

    Dr. Miklos is a professional, understanding, and I think he has a great since of humor.

    July 12, 2024
    UH HOSPITALS AND CLINICS

    As I have said before, his knowledge and professionalism is the most encompassing I have ever known. I am so thankful he continues to watch over my medical care.

    June 16, 2024
    UH HOSPITALS AND CLINICS

    He was fantastic an listened to us.

    June 13, 2024
    UH HOSPITALS AND CLINICS

    You will deeply appreciate his caring and thoughtful ways of responding to your concerns.

    See More Patient Comments

  • Dr. Miklos Z. Molnar is a Professor of Medicine and the Medical Director of the Kidney and Pancreas Transplantation Programs and Living Donor Transplantation Program at the Ï㽶ÊÓƵ of Utah Hospital and Clinics and the Director of the Kidney Clinics. Dr. Molnar obtained his M. D. and Ph. D. from Semmelweis Ï㽶ÊÓƵ, Budapest, Hungary. He completed his residency and fellowship in Europe then immigrated to USA in 2010. Dr. Molnar completed residency in Internal Medicine and received additional specialized training and faculty experience as a transplant nephrologist at Ï㽶ÊÓƵ of Tennessee Health Science Center, Memphis, TN after he completed his North American nephrology fellowship training at Ï㽶ÊÓƵ of Toronto, Ontario, Canada. Dr. Molnar is board certified in Internal Medicine and Nephrology. Dr. Molnar is also board certified in Internal Medicine, Nephrology and Transplant Medicine in Europe. His primary clinical interests involve all aspects of kidney transplantation including candidate evaluation for recipients and living donors, processes of care around organ procurement and quality assessment, and perioperative as well as long-term care of recipients and their donors. In addition, Dr. Molnar’s clinical interests include the medical evaluation and care of pancreas transplant recipients as well as the prevention, diagnosis and treatment of various native kidney diseases and acute kidney injury. Dr. Molnar’s primary research interests involve outcome research in kidney transplant recipients. Dr. Molnar is active in clinical research and frequently gives talks in national and international meetings. Dr. Molnar is a primary, senior author or co-author of more than 300 articles in the field of nephrology and transplant medicine. He serves as an Editorial board member for several journals.

    Languages spoken: English, Hungarian

    Board Certification and Academic Information

    Academic Departments Internal Medicine -Primary
    Academic Divisions Nephrology & Hypertension
    Board Certification
    American Board of Internal Medicine (Internal Medicine)
    American Board of Internal Medicine (Sub: Nephrology)
    Educational Commission for Foreign Medical Graduates
    European Board of Internal Medicine (EBIM)
    European Board of Transplant Medicine (EBTM)
    National Board of Medical Examiners

    Education history

    Fellowship Transplant Nephrology - Methodist Healthcare, Transplant Institute Fellow
    Residency Internal Medicine - Ï㽶ÊÓƵ of Tennessee Health Science Center Resident
    Fellowship Nephrology & Kidney Transplantation - Ï㽶ÊÓƵ of Toronto, Ï㽶ÊÓƵ Health Network Advanced Clinical Fellow
    Fellowship Nephrology & Kidney Transplantation - Harbor-UCLA Medical Center, LA BioMed Postdoctoral Research Fellow
    Fellowship Transplant Nephrology - Semmelweis Ï㽶ÊÓƵ Fellow
    Fellowship Nephrology - Semmelweis Ï㽶ÊÓƵ Fellow
    Professional Medical Clinical Medicine - Semmelweis Ï㽶ÊÓƵ Faculty of General Medicine PHD
    Residency Internal Medicine - Semmelweis Ï㽶ÊÓƵ Resident
    Professional Medical Medicine - Semmelweis Ï㽶ÊÓƵ Faculty of Medicine M.D.

    Selected Publications

    Journal Article

    1. Cseprekal O, Van Craenenbroeck AH, de Borst MH, Stevens KI, Ferreira AC, Molnar MZ, Pettinelli P, Wiecek A (2024). The Young Nephrologists' Platform: the gateway to the future of nephrology. Clin Kidney J, 17(3), sfae024. ()
    2. Sarwal A, Yamauchi J, Raghavan D, Shihab F, Fornadi K, Rofaiel G, Zimmerman M, Campsen J, Baker N, Akhila Ganireddy Y, Aviles-Ovalle L, Baker T, Hall IE, Molnar MZ (2023). Throwing stones: kidney stone incidence in living kidney donor candidates with increased metabolic risk. Ren Fail, 45(1), 2226763. ()
    3. Yamauchi J, Raghavan D, Rofaiel G, Zimmerman M, Potluri VS, Baker T, Campsen J, Hall IE, Molnar MZ (2023). Therapeutic Donor Kidney Transplant Outcomes: Comparing Early US Experiences Using Optimal Matching. Transplant Direct, 9(12), e1554. ()
    4. Yamauchi J, Azhar A, Hall IE, Bhalla A, Potluri VS, Tanriover B, Gupta G, Imlay H, Truax C, Balaraman V, Raghavan D, Zimmerman M, Campsen J, Rofaiel G, Baker T, Molnar MZ (2023). Comparison of Short-Term Outcomes in Kidney Transplant Recipients from SARS-CoV-2-Infected versus Noninfected Deceased Donors. Clin J Am Soc Nephrol, 18(11), 1466-1475. ()
    5. Potukuchi PK, Moradi H, Park F, Kaplan C, Thomas F, Dashputre AA, Sumida K, Molnar MZ, Gaipov A, Gatwood JD, Rhee C, Streja E, Kalantar-Zadeh K, Kovesdy CP (2021). Cannabis Use and Risk of Acute Kidney Injury in Patients with Advanced Chronic Kidney Disease Transitioning to Dialysis. Cannabis Cannabinoid Res, 8(1), 138-147. ()
    6. Azhar A, Tsujita M, Talwar M, Balaraman V, Bhalla A, Eason JD, Nouer SS, Sumida K, Remport A, Hall IE, Griffin R, Rofaiel G, Molnar MZ (2022). CMV specific T cell immune response in hepatitis C negative kidney transplant recipients receiving transplant from hepatitis C viremic donors and hepatitis C aviremic donors. Ren Fail, 44(1), 831-841. ()
    7. Kothadia JP, Bhalla A, Molnar MZ, Mohan R, Balaraman V, Talwar M, Helmick R, Eymard C, Clark I, Jain R, Faust TW, Vanatta JM, Eason JD, Nair SP (2022). Liver Outcome in Renal Transplant Recipients Who Acquired Hepatitis C Infection From an Infected Graft: Study Based on Liver Biopsy Findings. Transplant Direct, 8(6), e1342. ()
    8. Molnar MZ, Potluri VS, Schaubel DE, Sise ME, Concepcion BP, Forbes RC, Blumberg E, Bloom RD, Shaffer D, Chung RT, Strohbehn IA, Elias N, Azhar A, Shah M, Sawinski D, Binari LA, Talwar M, Balaraman V, Bhalla A, Eason JD, Besharatian B, Trofe-Clark J, Goldberg DS, Reese PP (2021). Association of donor hepatitis C virus infection status and risk of BK polyomavirus viremia after kidney transplantation. Am J Transplant, 22(2), 599-609. ()
    9. Bleyer AJ, Westemeyer M, Xie J, Bloom MS, Brossart K, Eckel JJ, Jones F, Molnar MZ, Kotzker W, Anand P, Kmoch S, Xue Y, Strom S, Punj S, Demko ZP, Tabriziani H, Billings PR, McKanna T (2022). Genetic Etiologies for Chronic Kidney Disease Revealed through Next-Generation Renal Gene Panel. Am J Nephrol, 53(4), 297-306. ()
    10. Azhar A, Binari LA, Joglekar K, Tsujita M, Talwar M, Balaraman V, Bhalla A, Eason JD, Hall IE, Rofaiel G, Forbes RC, Shaffer D, Concepcion BP, Molnar MZ (2021). Association between ezetimibe usage and hepatitis C RNA levels in uninfected kidney transplant recipients who received hepatitis C infected kidneys. Clin Transplant, 35(12), e14485. ()
    11. Dashputre AA, Gatwood J, Sumida K, Thomas F, Akbilgic O, Potukuchi PK, Obi Y, Molnar MZ, Streja E, Kalantar-Zadeh K, Kovesdy CP (2021). Association of dyskalemias with short-term health care utilization in patients with advanced CKD. J Manag Care Spec Pharm, 27(10), 1403-1415. ()
    12. Alhamad T, Lubetzky M, Lentine KL, Edusei E, Parsons R, Pavlakis M, Woodside KJ, Adey D, Blosser CD, Concepcion BP, Friedewald J, Wiseman A, Singh N, Chang SH, Gupta G, Molnar MZ, Basu A, Kraus E, Ong S, Faravardeh A, Tantisattamo E, Riella L, Rice J, Dadhania DM (2021). Kidney recipients with allograft failure, transition of kidney care (KRAFT): A survey of contemporary practices of transplant providers. Am J Transplant, 21(9), 3034-3042. ()
    13. Rofaiel G, Molnar MZ, Baker N, Campsen J, Kim R (2021). Robotic-assisted Kidney Transplantation With Simultaneous Bilateral Nephrectomies Is an Efficient, Feasible, and Safe Way to Manage Patients With Renal Failure Secondary to Adult Polycystic Kidney Disease. Transplant Direct, 7(9), e740. ()
    14. Molnar MZ, Azhar A, Tsujita M, Talwar M, Balaraman V, Bhalla A, Podila PSB, Kothadia J, Agbim UA, Maliakkal B, Satapathy SK, Kovesdy CP, Nair S, Eason JD (2020). Transplantation of Kidneys From Hepatitis C Virus-Infected Donors to Hepatitis C Virus-Negative Recipients: One-Year Kidney Allograft Outcomes. Am J Kidney Dis, 77(5), 739-747.e1. ()
    15. Gupta V, Ekundayo O, Nemeth ZK, Yang Y, Covic A, Mathe Z, Kovesdy CP, Molnar MZ, Mucsi I (2021). Association between serum osteoprotegerin level and mortality in kidney transplant recipients - a prospective observational cohort study. Transpl Int, 34(5), 844-854. ()
    16. Sumida K, Dashputre AA, Potukuchi PK, Thomas F, Obi Y, Molnar MZ, Gatwood JD, Streja E, Kalantar-Zadeh K, Kovesdy CP (2021). Laxative Use and Risk of Dyskalemia in Patients with Advanced CKD Transitioning to Dialysis. J Am Soc Nephrol, 32(4), 950-959. ()
    17. Dashputre AA, Potukuchi PK, Sumida K, Kar S, Obi Y, Thomas F, Molnar MZ, Streja E, Kalantar-Zadeh K, Kovesdy CP (2021). Predialysis Potassium Variability and Postdialysis Mortality in Patients With Advanced CKD. Kidney Int Rep, 6(2), 366-380. ()
    18. Dashputre AA, Sumida K, Potukuchi PK, Kar S, Obi Y, Thomas F, Molnar MZ, Streja E, Kalantar-Zadeh K, Kovesdy CP (2021). Potassium Trajectories prior to Dialysis and Mortality following Dialysis Initiation in Patients with Advanced CKD. Nephron, 145(3), 265-274. ()
    19. Dashputre AA, Sumida K, Thomas F, Gatwood J, Akbilgic O, Potukuchi PK, Obi Y, Molnar MZ, Streja E, Kalantar Zadeh K, Kovesdy CP (2021). Association of Dyskalemias with Ischemic Stroke in Advanced Chronic Kidney Disease Patients Transitioning to Dialysis. Am J Nephrol, 52(7), 539-547. ()
    20. Yazawa M, Cseprekal O, Helmick RA, Talwar M, Balaraman V, Podila PSB, Fossey S, Satapathy SK, Eason JD, Molnar MZ (2019). Association between longer hospitalization and development of de novo donor specific antibodies in simultaneous liver-kidney transplant recipients. Ren Fail, 42(1), 40-47. ()
    21. Hayek SS, Brenner SK, Azam TU, Shadid HR, Anderson E, Berlin H, Pan M, Meloche C, Feroz R, OHayer P, Kaakati R, Bitar A, Padalia K, Perry D, Blakely P, Gupta S, Shaefi S, Srivastava A, Charytan DM, Bansal A, Mallappallil M, Melamed ML, Shehata AM, Sunderram J, Mathews KS, Sutherland AK, Nallamothu BK, Leaf DE, STOP-COVID Investigators (2020). In-hospital cardiac arrest in critically ill patients with covid-19: multicenter cohort study. BMJ, 371, m3513. ()
    22. Gupta S, Hayek SS, Wang W, Chan L, Mathews KS, Melamed ML, Brenner SK, Leonberg-Yoo A, Schenck EJ, Radbel J, Reiser J, Bansal A, Srivastava A, Zhou Y, Sutherland A, Green A, Shehata AM, Goyal N, Vijayan A, Velez JCQ, Shaefi S, Parikh CR, Arunthamakun J, Athavale AM, Friedman AN, Short SAP, Kibbelaar ZA, Abu Omar S, Admon AJ, Donnelly JP, Gershengorn HB, Hernn MA, Semler MW, Leaf DE, STOP-COVID Investigators (2020). Factors Associated With Death in Critically Ill Patients With Coronavirus Disease 2019 in the US. JAMA Intern Med. ()
    23. Agbim U, Sharma A, Maliakkal B, Karri S, Yazawa M, Goldkamp W, Podila PSB, Vanatta JM, Gonzalez H, Molnar MZ, Nair SP, Eason JD, Satapathy SK (2020). Outcomes of Liver Transplant Recipients With Acute-on-Chronic Liver Failure Based on EASL-CLIF Consortium Definition: A Single-center Study. Transplant Direct, 6(4), e544. ()
    24. Yazawa M, Cseprekal O, Helmick RA, Talwar M, Balaraman V, Podila PSB, Agbim UA, Maliakkal B, Fossey S, Satapathy SK, Sumida K, Kovesdy CP, Nair S, Eason JD, Molnar MZ (2019). Association between post-transplant donor-specific antibodies and recipient outcomes in simultaneous liver-kidney transplant recipients: single-center, cohort study. Transpl Int, 33(2), 202-215. ()
    25. Yazawa M, Cseprekal O, Helmick RA, Talwar M, Balaraman V, Podila PSB, Agbim UA, Maliakkal B, Fossey S, Satapathy SK, Sumida K, Kovesdy CP, Nair S, Eason JD, Molnar MZ (2020). Lack of Association between Pretransplant Donor-Specific Antibodies and Posttransplant Kidney Outcomes in Simultaneous Liver-Kidney Transplant Recipients with Rabbit Anti-Thymocyte Globulin Induction and Steroid-Free Protocol. Nephron, 144(3), 126-137. ()
    26. Soohoo M, Molnar MZ, Ujszaszi A, Obi Y, Kovesdy CP, Kalantar-Zadeh K, Streja E (2018). Red blood cell distribution width and mortality and hospitalizations in peritoneal dialysis patients. Nephrol Dial Transplant, 34(12), 2111-2118. ()
    27. Gaipov A, Molnar MZ, Potukuchi PK, Sumida K, Szabo Z, Akbilgic O, Streja E, Rhee CM, Koshy SKG, Canada RB, Kalantar-Zadeh K, Kovesdy CP (2018). Acute kidney injury following coronary revascularization procedures in patients with advanced CKD. Nephrol Dial Transplant, 34(11), 1894-1901. ()
    28. Molnar MZ, Nair S, Cseprekal O, Yazawa M, Talwar M, Balaraman V, Podila PSB, Mas V, Maluf D, Helmick RA, Campos L, Nezakatgoo N, Eymard C, Horton P, Verma R, Jenkins AH, Handley CR, Snyder HS, Cummings C, Agbim UA, Maliakkal B, Satapathy SK, Eason JD (2019). Transplantation of kidneys from hepatitis C-infected donors to hepatitis C-negative recipients: Single center experience. Am J Transplant, 19(11), 3046-3057. ()
    29. Potluri VS, Goldberg DS, Mohan S, Bloom RD, Sawinski D, Abt PL, Blumberg EA, Parikh CR, Sharpe J, Reddy KR, Molnar MZ, Sise M, Reese PP (2019). National Trends in Utilization and 1-Year Outcomes with Transplantation of HCV-Viremic Kidneys. J Am Soc Nephrol, 30(10), 1939-1951. ()
    30. Matsushita K, Sang Y, Yang C, Ballew SH, Grams ME, Coresh J, Molnar MZ (2019). Dyskalemia, its patterns, and prognosis among patients with incident heart failure: A nationwide study of US veterans. PLoS One, 14(8), e0219899. ()
    31. Siwakoti A, Potukuchi PK, Thomas F, Gaipov A, Talwar M, Balaraman V, Cseprekal O, Yazawa M, Streja E, Eason JD, Kalantar-Zadeh K, Kovesdy CP, Molnar MZ (2019). History of posttraumatic stress disorder and outcomes after kidney transplantation. Am J Transplant, 19(8), 2294-2305. ()
    32. Akbilgic O, Obi Y, Potukuchi PK, Karabayir I, Nguyen DV, Soohoo M, Streja E, Molnar MZ, Rhee CM, Kalantar-Zadeh K, Kovesdy CP (2019). Machine Learning to Identify Dialysis Patients at High Death Risk. Kidney Int Rep, 4(9), 1219-1229. ()
    33. Gaipov A, Jackson CD, Talwar M, Balaraman V, Chakravarty A, Cseprekal O, Mathe Z, Remport A, Kovesdy CP, Eason JD, Mucsi I, Molnar MZ (2019). Association Between Serum Prealbumin Level and Outcomes in Prevalent Kidney Transplant Recipients. J Ren Nutr, 29(3), 188-195. ()
    34. Soohoo M, Moradi H, Obi Y, Rhee CM, Gosmanova EO, Molnar MZ, Kashyap ML, Gillen DL, Kovesdy CP, Kalantar-Zadeh K, Streja E (2019). Statin Therapy Before Transition to End-Stage Renal Disease With Posttransition Outcomes. J Am Heart Assoc, 8(6), e011869. ()
    35. Molnar MZ, Joglekar K, Jiang Y, Cholankeril G, Abdul MKM, Kedia S, Gonzalez HC, Ahmed A, Singal A, Bhamidimarri KR, Aithal GP, Duseja A, Wong VW, Gulnare A, Puri P, Nair S, Eason JD, Satapathy SK, Global NAFLD Consortium (2018). Association of Pretransplant Renal Function With Liver Graft and Patient Survival After Liver Transplantation in Patients With Nonalcoholic Steatohepatitis. Liver Transpl, 25(3), 399-410. ()
    36. Rhee CM, Kovesdy CP, Ravel VA, Streja E, Sim JJ, You AS, Gatwood J, Amin AN, Molnar MZ, Nguyen DV, Kalantar-Zadeh K (2018). Glycemic Status and Mortality in Chronic Kidney Disease According to Transition Versus Nontransition to Dialysis. J Ren Nutr, 29(2), 82-90. ()
    37. Gaipov A, Cseprekal O, Potukuchi PK, Kabulbayev K, Remport A, Mathe Z, Talwar M, Balaraman V, Flp T, Eason JD, Mucsi I, Kovesdy CP, Molnar MZ (2018). Association between malnutrition-inflammation score and risk of subsequent self-reported bone fractures in prevalent kidney transplant recipients. Osteoporos Int, 30(3), 611-620. ()
    38. Gaipov A, Molnar MZ, Potukuchi PK, Sumida K, Canada RB, Akbilgic O, Kabulbayev K, Szabo Z, Koshy SKG, Kalantar-Zadeh K, Kovesdy CP (2018). Predialysis coronary revascularization and postdialysis mortality. J Thorac Cardiovasc Surg, 157(3), 976-983.e7. ()
    39. Coresh J, Heerspink HJL, Sang Y, Matsushita K, Arnlov J, Astor BC, Black C, Brunskill NJ, Carrero JJ, Feldman HI, Fox CS, Inker LA, Ishani A, Ito S, Jassal S, Konta T, Polkinghorne K, Romundstad S, Solbu MD, Stempniewicz N, Stengel B, Tonelli M, Umesawa M, Waikar SS, Wen CP, Wetzels JFM, Woodward M, Grams ME, Kovesdy CP, Levey AS, Gansevoort RT, Chronic Kidney Disease Prognosis Consortium and Chronic Kidney Disease Epidemiology Collaboration (2019). Change in albuminuria and subsequent risk of end-stage kidney disease: an individual participant-level consortium meta-analysis of observational studies. Lancet Diabetes Endocrinol, 7(2), 115-127. ()
    40. Sumida K, Molnar MZ, Potukuchi PK, Thomas F, Lu JL, Yamagata K, Kalantar-Zadeh K, Kovesdy CP (2018). Constipation and risk of death and cardiovascular events. Atherosclerosis, 281, 114-120. ()
    41. Dratch A, Kleine CE, Streja E, Soohoo M, Park C, Hsiung JT, Rhee CM, Obi Y, Molnar MZ, Kovesdy CP, Kalantar-Zadeh K (2019). Mean Corpuscular Volume and Mortality in Incident Hemodialysis Patients. Nephron, 141(3), 188-200. ()
    42. Gyamlani G, Potukuchi PK, Thomas F, Akbilgic O, Soohoo M, Streja E, Naseer A, Sumida K, Molnar MZ, Kalantar-Zadeh K, Kovesdy CP (2019). Vancomycin-Associated Acute Kidney Injury in a Large Veteran Population. Am J Nephrol, 49(2), 133-142. ()
    43. Rhee CM, Kovesdy CP, You AS, Sim JJ, Soohoo M, Streja E, Molnar MZ, Amin AN, Abbott K, Nguyen DV, Kalantar-Zadeh K (2018). Hypoglycemia-Related Hospitalizations and Mortality Among Patients With Diabetes Transitioning to Dialysis. Am J Kidney Dis, 72(5), 701-710. ()
    44. Carrero JJ, Thomas F, Nagy K, Arogundade F, Avesani CM, Chan M, Chmielewski M, Cordeiro AC, Espinosa-Cuevas A, Fiaccadori E, Guebre-Egziabher F, Hand RK, Hung AM, Ikizler TA, Johansson LR, Kalantar-Zadeh K, Karupaiah T, Lindholm B, Marckmann P, Mafra D, Parekh RS, Park J, Russo S, Saxena A, Sezer S, Teta D, Ter Wee PM, Verseput C, Wang AYM, Xu H, Lu Y, Molnar MZ, Kovesdy CP (2018). Global Prevalence of Protein-Energy Wasting in Kidney Disease: A Meta-analysis of Contemporary Observational Studies From the International Society of Renal Nutrition and Metabolism. J Ren Nutr, 28(6), 380-392. ()
    45. Lu JL, Freire AX, Molnar MZ, Kalantar-Zadeh K, Kovesdy CP (2017). Association of Chronic Insomnia With Mortality and Adverse Renal Outcomes. Mayo Clin Proc, 93(11), 1563-1570. ()
    46. Streja E, Gosmanova EO, Molnar MZ, Soohoo M, Moradi H, Potukuchi PK, Kalantar-Zadeh K, Kovesdy CP (2018). Association of Continuation of Statin Therapy Initiated Before Transition to Chronic Dialysis Therapy With Mortality After Dialysis Initiation. JAMA Netw Open, 1(6), e182311. ()
    47. Flp T, Tapolyai MB, Zsom L, Molnar MZ, Abdul Salim S, jhelyi L, Becs G, Balla J, Hamrahian M (2018). Successful Practice Transitioning Between Hemodialysis and Hemodiafiltration in Outpatient Units: Ten Key Issues for Physicians to Remember. Artif Organs, 42(9), 925-932. ()
    48. Obi Y, Nguyen DV, Zhou H, Soohoo M, Zhang L, Chen Y, Streja E, Sim JJ, Molnar MZ, Rhee CM, Abbott KC, Jacobsen SJ, Kovesdy CP, Kalantar-Zadeh K (2018). Development and Validation of Prediction Scores for Early Mortality at Transition to Dialysis. Mayo Clin Proc, 93(9), 1224-1235. ()
    49. Satapathy SK, Joglekar K, Molnar MZ, Ali B, Gonzalez HC, Vanatta JM, Eason JD, Nair SP (2017). Achieving Sustained Virological Response in Liver Transplant Recipients With Hepatitis C Decreases Risk of Decline in Renal Function. Liver Transpl, 24(8), 1040-1049. ()
    50. Reusz GS, Molnar MZ (2018). Are kidney transplantation outcomes improved in children weighting 15 kilograms or less in the last decades? Transpl Int, 31(7), 703-705. ()
    51. Kamal F, Khan MA, Molnar MZ, Howden CW (2018). The Association Between Proton Pump Inhibitor Use With Acute Kidney Injury and Chronic Kidney Disease. J Clin Gastroenterol, 52(6), 468-476. ()
    52. Grams ME, Sang Y, Ballew SH, Carrero JJ, Djurdjev O, Heerspink HJL, Ho K, Ito S, Marks A, Naimark D, Nash DM, Navaneethan SD, Sarnak M, Stengel B, Visseren FLJ, Wang AY, Kttgen A, Levey AS, Woodward M, Eckardt KU, Hemmelgarn B, Coresh J (2018). Predicting timing of clinical outcomes in patients with chronic kidney disease and severely decreased glomerular filtration rate. Kidney Int, 93(6), 1442-1451. ()
    53. Lu JL, Molnar MZ, Sumida K, Diskin CD, Streja E, Siddiqui OA, Kalantar-Zadeh K, Kovesdy CP (2017). Association of the frequency of pre-end-stage renal disease medical care with post-end-stage renal disease mortality and hospitalization. Nephrol Dial Transplant, 33(5), 789-795. ()
    54. Molnar MZ, Eason JD, Gaipov A, Talwar M, Potukuchi PK, Joglekar K, Remport A, Mathe Z, Mucsi I, Novak M, Kalantar-Zadeh K, Kovesdy CP (2018). History of psychosis and mania, and outcomes after kidney transplantation - a retrospective study. Transpl Int, 31(5), 554-565. ()
    55. Sumida K, Molnar MZ, Potukuchi PK, Hassan F, Thomas F, Yamagata K, Kalantar-Zadeh K, Kovesdy CP (2018). Treatment of rheumatoid arthritis with biologic agents lowers the risk of incident chronic kidney disease. Kidney Int, 93(5), 1207-1216. ()
    56. Molnar MZ (2017). Is kidney transplantation safe after careful selection of the recipients with a history of psychotic disorder? Transpl Int, 31(4), 364-366. ()
    57. Sumida K, Molnar MZ, Potukuchi PK, Thomas F, Lu JL, Obi Y, Rhee CM, Streja E, Yamagata K, Kalantar-Zadeh K, Kovesdy CP (2016). Prognostic significance of pre-end-stage renal disease serum alkaline phosphatase for post-end-stage renal disease mortality in late-stage chronic kidney disease patients transitioning to dialysis. Nephrol Dial Transplant, 33(2), 264-273. ()
    58. Streja E, Kalantar-Zadeh K, Molnar MZ, Landman J, Arah OA, Kovesdy CP (2016). Radical versus partial nephrectomy, chronic kidney disease progression and mortality in US veterans. Nephrol Dial Transplant, 33(1), 95-101. ()
    59. Kovesdy CP, Naseer A, Sumida K, Molnar MZ, Potukuchi PK, Thomas F, Streja E, Heung M, Abbott KC, Saran R, Kalantar-Zadeh K (2017). Abrupt Decline in Kidney Function Precipitating Initiation of Chronic Renal Replacement Therapy. Kidney Int Rep, 3(3), 602-609. ()
    60. Sumida K, Molnar MZ, Potukuchi PK, George K, Thomas F, Lu JL, Yamagata K, Kalantar-Zadeh K, Kovesdy CP (2017). Changes in Albuminuria and Subsequent Risk of Incident Kidney Disease. Clin J Am Soc Nephrol, 12(12), 1941-1949. ()
    61. Flp T, Zsom L, Tapolyai MB, Molnar MZ, Abdul Salim S, Arany I, Hamrahian M, Rosivall L (2017). Peritoneal dialysis: The unique features by compartmental delivery of renal replacement therapy. Med Hypotheses, 108, 128-132. ()
    62. Molnar MZ, Streja E, Sumida K, Soohoo M, Ravel VA, Gaipov A, Potukuchi PK, Thomas F, Rhee CM, Lu JL, Kalantar-Zadeh K, Kovesdy CP (2017). Pre-ESRD Depression and Post-ESRD Mortality in Patients with Advanced CKD Transitioning to Dialysis. Clin J Am Soc Nephrol, 12(9), 1428-1437. ()
    63. Molnar MZ, Nagy K, Remport A, Tapolyai MB, Flp T, Kamal F, Kovesdy CP, Mucsi I, Mathe Z (2016). Inflammatory Markers and Outcomes in Kidney Transplant Recipients. Transplantation, 101(9), 2152-2164. ()
    64. Flp T, Tapolyai MB, Agarwal M, Lopez-Ruiz A, Molnar MZ, Dossabhoy NR (2016). Bedside Tunneled Dialysis Catheter Removal-A Lesson Learned From Nephrology Trainees. Artif Organs, 41(9), 810-817. ()
    65. Sumida K, Molnar MZ, Potukuchi PK, Thomas F, Lu JL, Yamagata K, Kalantar-Zadeh K, Kovesdy CP (2017). Pre-end-stage renal disease visit-to-visit systolic blood pressure variability and post-end-stage renal disease mortality in incident dialysis patients. J Hypertens, 35(9), 1816-1824. ()
    66. Sumida K, Molnar MZ, Potukuchi PK, Thomas F, Lu JL, Ravel VA, Soohoo M, Rhee CM, Streja E, Yamagata K, Kalantar-Zadeh K, Kovesdy CP (2016). Association between vascular access creation and deceleration of estimated glomerular filtration rate decline in late-stage chronic kidney disease patients transitioning to end-stage renal disease. Nephrol Dial Transplant, 32(8), 1330-1337. ()
    67. Sumida K, Molnar MZ, Potukuchi PK, Thomas F, Lu JL, Ravel VA, Soohoo M, Rhee CM, Streja E, Sim JJ, Yamagata K, Kalantar-Zadeh K, Kovesdy CP (2017). Blood Pressure Before Initiation of Maintenance Dialysis and Subsequent Mortality. Am J Kidney Dis, 70(2), 207-217. ()
    68. Chen Y, Sang Y, Ballew SH, Tin A, Chang AR, Matsushita K, Coresh J, Kalantar-Zadeh K, Molnar MZ, Grams ME (2017). Race, Serum Potassium, and Associations With ESRD and Mortality. Am J Kidney Dis, 70(2), 244-251. ()
    69. Rhee CM, Kovesdy CP, Ravel VA, Streja E, Brunelli SM, Soohoo M, Sumida K, Molnar MZ, Brent GA, Nguyen DV, Kalantar-Zadeh K (2017). Association of Glycemic Status During Progression of Chronic Kidney Disease With Early Dialysis Mortality in Patients With Diabetes. Diabetes Care, 40(8), 1050-1057. ()
    70. Ronai KZ, Szentkiralyi A, Lazar AS, Lazar ZI, Papp I, Gombos F, Zoller R, Czira ME, Lindner AV, Mucsi I, Bodizs R, Molnar MZ, Novak M (2017). Association of symptoms of insomnia and sleep parameters among kidney transplant recipients. J Psychosom Res, 99, 95-104. ()
    71. George LK, Koshy SKG, Molnar MZ, Thomas F, Lu JL, Kalantar-Zadeh K, Kovesdy CP (2016). Heart Failure Increases the Risk of Adverse Renal Outcomes in Patients With Normal Kidney Function. Circ Heart Fail, 10(8). ()
    72. Joglekar K, Eason JD, Molnar MZ (2017). Do we really need more evidence to use hepatitis C positive donor kidney more liberally? Clin Kidney J, 10(4), 560-563. ()
    73. Molnar MZ, Nguyen DV, Chen Y, Ravel V, Streja E, Krishnan M, Kovesdy CP, Mehrotra R, Kalantar-Zadeh K (2016). Predictive Score for Posttransplantation Outcomes. Transplantation, 101(6), 1353-1364. ()
    74. Ronai KZ, Szentkiralyi A, Lazar AS, Ujszaszi A, Turanyi C, Gombos F, Mucsi I, Bodizs R, Molnar MZ, Novak M (2017). Depressive Symptoms Are Associated With Objectively Measured Sleep Parameters in Kidney Transplant Recipients. J Clin Sleep Med, 13(4), 557-564. ()
    75. Sumida K, Molnar MZ, Potukuchi PK, Thomas F, Lu JL, Matsushita K, Yamagata K, Kalantar-Zadeh K, Kovesdy CP (2016). Constipation and Incident CKD. J Am Soc Nephrol, 28(4), 1248-1258. ()
    76. Kalantar-Zadeh K, Kovesdy CP, Streja E, Rhee CM, Soohoo M, Chen JLT, Molnar MZ, Obi Y, Gillen D, Nguyen DV, Norris KC, Sim JJ, Jacobsen SS (2016). Transition of care from pre-dialysis prelude to renal replacement therapy: the blueprints of emerging research in advanced chronic kidney disease. Nephrol Dial Transplant, 32(suppl_2), ii91-ii98. ()
    77. Szatmari S Jr, Bereczki D, Fornadi K, Kalantar-Zadeh K, Kovesdy CP, Molnar MZ (2017). Association of Restless Legs Syndrome With Incident Parkinson's Disease. Sleep, 40(2). ()
    78. Wang J, Streja E, Soohoo M, Chen JL, Rhee CM, Kim T, Molnar MZ, Kovesdy CP, Mehrotra R, Kalantar-Zadeh K (2016). Concurrence of Serum Creatinine and Albumin With Lower Risk for Death in Twice-Weekly Hemodialysis Patients. J Ren Nutr, 27(1), 26-36. ()
    79. Molnar MZ, Nagy K, Remport A, Gaipov A, Flp T, Czira ME, Kovesdy CP, Mucsi I, Mathe Z (2016). Association Between Serum Leptin Level and Mortality in Kidney Transplant Recipients. J Ren Nutr, 27(1), 53-61. ()
    80. Gyamlani G, Molnar MZ, Lu JL, Sumida K, Kalantar-Zadeh K, Kovesdy CP (2016). Association of serum albumin level and venous thromboembolic events in a large cohort of patients with nephrotic syndrome. Nephrol Dial Transplant, 32(1), 157-164. ()
    81. Arif FM, Sumida K, Molnar MZ, Potukuchi PK, Lu JL, Hassan F, Thomas F, Siddiqui OA, Gyamlani GG, Kalantar-Zadeh K, Kovesdy CP (2017). Early Mortality Associated with Inpatient versus Outpatient Hemodialysis Initiation in a Large Cohort of US Veterans with Incident End-Stage Renal Disease. Nephron, 137(1), 15-22. ()
    82. Molnar MZ, Sumida K, Gaipov A, Potukuchi PK, Flp T, Joglekar K, Lu JL, Streja E, Kalantar-Zadeh K, Kovesdy CP (2017). Pre-ESRD Dementia and Post-ESRD Mortality in a Large Cohort of Incident Dialysis Patients. Dement Geriatr Cogn Disord, 43(5-6), 281-293. ()
    83. Saleh T, Sumida K, Molnar MZ, Potukuchi PK, Thomas F, Lu JL, Gyamlani GG, Streja E, Kalantar-Zadeh K, Kovesdy CP (2017). Effect of Age on the Association of Vascular Access Type with Mortality in a Cohort of Incident End-Stage Renal Disease Patients. Nephron, 137(1), 57-63. ()
    84. Sumida K, Diskin CD, Molnar MZ, Potukuchi PK, Thomas F, Lu JL, Rhee CM, Streja E, Yamagata K, Kalantar-Zadeh K, Kovesdy CP (2017). Pre-End-Stage Renal Disease Hemoglobin Variability Predicts Post-End-Stage Renal Disease Mortality in Patients Transitioning to Dialysis. Am J Nephrol, 46(5), 397-407. ()
    85. Rivara MB, Adams SV, Kuttykrishnan S, Kalantar-Zadeh K, Arah OA, Cheung AK, Katz R, Molnar MZ, Ravel V, Soohoo M, Streja E, Himmelfarb J, Mehrotra R (2016). Extended-hours hemodialysis is associated with lower mortality risk in patients with end-stage renal disease. Kidney Int, 90(6), 1312-1320. ()
    86. Lu JL, Molnar MZ, Ma JZ, George LK, Sumida K, Kalantar-Zadeh K, Kovesdy CP (2016). Racial Differences in Association of Serum Calcium with Mortality and Incident Cardio- and Cerebrovascular Events. J Clin Endocrinol Metab, 101(12), 4851-4859. ()
    87. Flp T, Zsom L, Tapolyai MB, Molnar MZ, Rosivall L (2016). Volume-related weight gain as an independent indication for renal replacement therapy in the intensive care units. J Renal Inj Prev, 6(1), 35-42. ()
    88. Novak M, Mucsi I, Rhee CM, Streja E, Lu JL, Kalantar-Zadeh K, Molnar MZ, Kovesdy CP (2016). Increased Risk of Incident Chronic Kidney Disease, Cardiovascular Disease, and Mortality in Patients With Diabetes With Comorbid Depression. Diabetes Care, 39(11), 1940-1947. ()
    89. Bhandari SK, Shi J, Molnar MZ, Rasgon SA, Derose SF, Kovesdy CP, Calhoun DA, Kalantar-Zadeh K, Jacobsen SJ, Sim JJ (2016). Comparisons of sleep apnoea rate and outcomes among patients with resistant and non-resistant hypertension. Respirology, 21(8), 1486-1492. ()
    90. Molnar MZ, Ravel V, Streja E, Kovesdy CP, Mehrotra R, Kalantar-Zadeh K (2015). Racial Differences in Survival of Incident Home Hemodialysis and Kidney Transplant Patients. Transplantation, 100(10), 2203-10. ()
    91. Molnar MZ, Gosmanova EO, Sumida K, Potukuchi PK, Lu JL, Jing J, Ravel VA, Soohoo M, Rhee CM, Streja E, Kalantar-Zadeh K, Kovesdy CP (2016). Predialysis Cardiovascular Disease Medication Adherence and Mortality After Transition to Dialysis. Am J Kidney Dis, 68(4), 609-618. ()
    92. Kim S, Molnar MZ, Fonarow GC, Streja E, Wang J, Gillen DL, Mehrotra R, Brunelli SM, Kovesdy CP, Kalantar-Zadeh K, Rhee CM (2016). Mean platelet volume and mortality risk in a national incident hemodialysis cohort. Int J Cardiol, 220, 862-70. ()
    93. Gaipov A, Solak Y, Zhampeissov N, Dzholdasbekova A, Popova N, Molnar MZ, Tuganbekova S, Iskandirova E (2016). Renal functional reserve and renal hemodynamics in hypertensive patients. Ren Fail, 38(9), 1391-1397. ()
    94. Molnar MZ, Ravel V, Streja E, Kovesdy CP, Rivara MB, Mehrotra R, Kalantar-Zadeh K (2016). Survival of Elderly Adults Undergoing Incident Home Hemodialysis and Kidney Transplantation. J Am Geriatr Soc, 64(10), 2003-2010. ()
    95. Gosmanova EO, Mikkelsen MK, Molnar MZ, Lu JL, Yessayan LT, Kalantar-Zadeh K, Kovesdy CP (2016). Association of Systolic Blood Pressure Variability With Mortality, Coronary Heart Disease, Stroke, and Renal Disease. J Am Coll Cardiol, 68(13), 1375-1386. ()
    96. Grams ME, Sang Y, Coresh J, Ballew SH, Matsushita K, Levey AS, Greene TH, Molnar MZ, Szabo Z, Kalantar-Zadeh K, Kovesdy CP (2016). Candidate Surrogate End Points for ESRD after AKI. J Am Soc Nephrol, 27(9), 2851-9. ()
    97. Nagy K, Ujszaszi A, Remport A, Kovesdy CP, Mucsi I, Molnar MZ, Mathe Z (2016). Association of Abdominal Circumference, Body Mass Index, and Inflammation in Kidney Transplant Recipients. J Ren Nutr, 26(5), 325-33. ()
    98. Molnar-Varga M, Novak M, Szabo AJ, Kelen K, Streja E, Remport A, Mucsi I, Molnar MZ, Reusz G (2016). Neurocognitive functions of pediatric kidney transplant recipients. Pediatr Nephrol, 31(9), 1531-8. ()
    99. Norris KC, Mensah GA, Boulware LE, Lu JL, Ma JZ, Streja E, Molnar MZ, Kalantar-Zadeh K, Kovesdy CP (2016). Age, Race and Cardiovascular Outcomes in African American Veterans. Ethn Dis, 26(3), 305-14. ()
    100. Mehrotra R, Soohoo M, Rivara MB, Himmelfarb J, Cheung AK, Arah OA, Nissenson AR, Ravel V, Streja E, Kuttykrishnan S, Katz R, Molnar MZ, Kalantar-Zadeh K (2015). Racial and Ethnic Disparities in Use of and Outcomes with Home Dialysis in the United States. J Am Soc Nephrol, 27(7), 2123-34. ()
    101. Vashistha T, Streja E, Molnar MZ, Rhee CM, Moradi H, Soohoo M, Kovesdy CP, Kalantar-Zadeh K (2016). Red Cell Distribution Width and Mortality in Hemodialysis Patients. Am J Kidney Dis, 68(1), 110-21. ()
    102. Tapolyai MB, Faludi M, Berta K, Szarvas T, Lengvrszky Z, Molnar MZ, Dossabhoy NR, Flp T (2016). The effect of ambient temperature and humidity on interdialytic weight gains in end-stage renal disease patients on maintenance hemodialysis. Int Urol Nephrol, 48(7), 1171-6. ()
    103. Grams ME, Sang Y, Coresh J, Ballew S, Matsushita K, Molnar MZ, Szabo Z, Kalantar-Zadeh K, Kovesdy CP (2015). Acute Kidney Injury After Major Surgery: A Retrospective Analysis of Veterans Health Administration Data. Am J Kidney Dis, 67(6), 872-80. ()
    104. Nagy K, Nagaraju SP, Rhee CM, Mathe Z, Molnar MZ (2016). Adipocytokines in renal transplant recipients. Clin Kidney J, 9(3), 359-73. ()
    105. Kovesdy CP, Alrifai A, Gosmanova EO, Lu JL, Canada RB, Wall BM, Hung AM, Molnar MZ, Kalantar-Zadeh K (2016). Age and Outcomes Associated with BP in Patients with Incident CKD. Clin J Am Soc Nephrol, 11(5), 821-31. ()
    106. Ravel V, Streja E, Molnar MZ, Rezakhani S, Soohoo M, Kovesdy CP, Kalantar-Zadeh K, Moradi H (2015). Association of aspartate aminotransferase with mortality in hemodialysis patients. Nephrol Dial Transplant, 31(5), 814-22. ()
    107. Gosmanov AR, Lu JL, Sumida K, Potukuchi PK, Rhee CM, Kalantar-Zadeh K, Molnar MZ, Kovesdy CP (2016). Synergistic association of combined glycemic and blood pressure level with risk of complications in US veterans with diabetes. J Hypertens, 34(5), 907-13. ()
    108. Nagy K, Ujszaszi A, Czira ME, Remport A, Kovesdy CP, Mathe Z, Rhee CM, Mucsi I, Molnar MZ (2016). Association between serum resistin level and outcomes in kidney transplant recipients. Transpl Int, 29(3), 352-61. ()
    109. Rivara MB, Soohoo M, Streja E, Molnar MZ, Rhee CM, Cheung AK, Katz R, Arah OA, Nissenson AR, Himmelfarb J, Kalantar-Zadeh K, Mehrotra R (2016). Association of Vascular Access Type with Mortality, Hospitalization, and Transfer to In-Center Hemodialysis in Patients Undergoing Home Hemodialysis. Clin J Am Soc Nephrol, 11(2), 298-307. ()
    110. Grams ME, Sang Y, Levey AS, Matsushita K, Ballew S, Chang AR, Chow EK, Kasiske BL, Kovesdy CP, Nadkarni GN, Shalev V, Segev DL, Coresh J, Lentine KL, Garg AX, Chronic Kidney Disease Prognosis Consortium (2015). Kidney-Failure Risk Projection for the Living Kidney-Donor Candidate. N Engl J Med, 374(5), 411-21. ()
    111. Molnar MZ, Lu JL, Kalantar-Zadeh K, Kovesdy CP (2015). Association of incident restless legs syndrome with outcomes in a large cohort of US veterans. J Sleep Res, 25(1), 47-56. ()
    112. Sumida K, Molnar MZ, Potukuchi PK, Thomas F, Lu JL, Jing J, Ravel VA, Soohoo M, Rhee CM, Streja E, Kalantar-Zadeh K, Kovesdy CP (2015). Association of Slopes of Estimated Glomerular Filtration Rate With Post-End-Stage Renal Disease Mortality in Patients With Advanced Chronic Kidney Disease Transitioning to Dialysis. Mayo Clin Proc, 91(2), 196-207. ()
    113. George LK, Molnar MZ, Lu JL, Kalantar-Zadeh K, Koshy SK, Kovesdy CP (2015). Association of Pre-Operative Albuminuria with Post-Operative Outcomes after Coronary Artery Bypass Grafting. Sci Rep, 5, 16458. ()
    114. Mehrotra R, Ravel V, Streja E, Kuttykrishnan S, Adams SV, Katz R, Molnar MZ, Kalantar-Zadeh K (2015). Peritoneal Equilibration Test and Patient Outcomes. Clin J Am Soc Nephrol, 10(11), 1990-2001. ()
    115. Remport A, Ivanyi B, Mathe Z, Tinckam K, Mucsi I, Molnar MZ (2014). Better understanding of transplant glomerulopathy secondary to chronic antibody-mediated rejection. Nephrol Dial Transplant, 30(11), 1825-33. ()
    116. Ahmadi SF, Streja E, Zahmatkesh G, Streja D, Kashyap M, Moradi H, Molnar MZ, Reddy U, Amin AN, Kovesdy CP, Kalantar-Zadeh K (2015). Reverse Epidemiology of Traditional Cardiovascular Risk Factors in the Geriatric Population. J Am Med Dir Assoc, 16(11), 933-9. ()
    117. Kovesdy CP, Norris KC, Boulware LE, Lu JL, Ma JZ, Streja E, Molnar MZ, Kalantar-Zadeh K (2015). Association of Race With Mortality and Cardiovascular Events in a Large Cohort of US Veterans. Circulation, 132(16), 1538-48. ()
    118. Nemeth ZK, Mardare NG, Czira ME, Deak G, Kiss I, Mathe Z, Remport A, Ujszaszi A, Covic A, Molnar MZ, Mucsi I (2015). Serum osteoprotegerin is associated with pulse pressure in kidney transplant recipients. Sci Rep, 5, 14518. ()
    119. Molnar MZ, Mucsi I, Novak M, Szabo Z, Freire AX, Huch KM, Arah OA, Ma JZ, Lu JL, Sim JJ, Streja E, Kalantar-Zadeh K, Kovesdy CP (2015). Association of incident obstructive sleep apnoea with outcomes in a large cohort of US veterans. Thorax, 70(9), 888-95. ()
    120. Lu JL, Molnar MZ, Naseer A, Mikkelsen MK, Kalantar-Zadeh K, Kovesdy CP (2015). Association of age and BMI with kidney function and mortality: a cohort study. Lancet Diabetes Endocrinol, 3(9), 704-14. ()
    121. Kuttykrishnan S, Kalantar-Zadeh K, Arah OA, Cheung AK, Brunelli S, Heagerty PJ, Katz R, Molnar MZ, Nissenson A, Ravel V, Streja E, Himmelfarb J, Mehrotra R (2015). Predictors of treatment with dialysis modalities in observational studies for comparative effectiveness research. Nephrol Dial Transplant, 30(7), 1208-17. ()
    122. Molnar MZ, Carrero JJ, Mucsi I, Remport A, Rhee CM, Kalantar-Zadeh K, Kovesdy CP, Cordeiro AC (2015). Comparison of the malnutrition-inflammation score in chronic kidney disease patients and kidney transplant recipients. Int Urol Nephrol, 47(6), 1025-33. ()
    123. Amparo FC, Kamimura MA, Molnar MZ, Cuppari L, Lindholm B, Amodeo C, Carrero JJ, Cordeiro AC (2014). Diagnostic validation and prognostic significance of the Malnutrition-Inflammation Score in nondialyzed chronic kidney disease patients. Nephrol Dial Transplant, 30(5), 821-8. ()
    124. Molnar MZ, Alhourani HM, Wall BM, Lu JL, Streja E, Kalantar-Zadeh K, Kovesdy CP (2015). Association of hepatitis C viral infection with incidence and progression of chronic kidney disease in a large cohort of US veterans. Hepatology, 61(5), 1495-502. ()
    125. Gosmanova EO, Molnar MZ, Alrifai A, Lu JL, Streja E, Cushman WC, Kalantar-Zadeh K, Kovesdy CP (2015). Impact of Non-Adherence on Renal and Cardiovascular Outcomes in US Veterans. Am J Nephrol, 42(2), 151-7. ()
    126. Fornadi K, Ronai KZ, Turanyi CZ, Malavade TS, Shapiro CM, Novak M, Mucsi I, Molnar MZ (2014). Sleep apnea is not associated with worse outcomes in kidney transplant recipients. Sci Rep, 4, 6987. ()
    127. Rhee CM, Molnar MZ, Lau WL, Ravel V, Kovesdy CP, Mehrotra R, Kalantar-Zadeh K (2014). Comparative mortality-predictability using alkaline phosphatase and parathyroid hormone in patients on peritoneal dialysis and hemodialysis. Perit Dial Int, 34(7), 732-48. ()
    128. Turnyi CZ, Rnai KZ, Zoller R, Vber O, Czira ME, jszszi, Lszl G, Szentkirlyi A, Dunai A, Lindner A, Szcs JL, Becze, Kelemen A, Lendvai Z, Molnar MZ, Mucsi I, Novk M (2014). Association between lunar phase and sleep characteristics. Sleep Med, 15(11), 1411-6. ()
    129. Kovesdy CP, Lu JL, Molnar MZ, Ma JZ, Canada RB, Streja E, Kalantar-Zadeh K, Bleyer AJ (2014). Observational modeling of strict vs conventional blood pressure control in patients with chronic kidney disease. JAMA Intern Med, 174(9), 1442-9. ()
    130. Dukkipati R, Molnar MZ, Park J, Jing J, Kovesdy CP, Kajani R, Kalantar-Zadeh K (2013). Association of vascular access type with inflammatory marker levels in maintenance hemodialysis patients. Semin Dial, 27(4), 415-23. ()
    131. Molnar MZ, Kmpers P, Kielstein JT, Schiffer M, Czira ME, Ujszaszi A, Kovesdy CP, Mucsi I (2014). Circulating Angiopoietin-2 levels predict mortality in kidney transplant recipients: a 4-year prospective case-cohort study. Transpl Int, 27(6), 541-52. ()
    132. Shapiro BB, Streja E, Rhee CM, Molnar MZ, Kheifets L, Kovesdy CP, Kopple JD, Kalantar-Zadeh K (2014). Revisiting the association between altitude and mortality in dialysis patients. Hemodial Int, 18(2), 374-83. ()
    133. Molnar MZ, Naser MS, Rhee CM, Kalantar-Zadeh K, Bunnapradist S (2013). Bone and mineral disorders after kidney transplantation: therapeutic strategies. Transplant Rev (Orlando), 28(2), 56-62. ()
    134. Streja E, Wang HY, Lau WL, Molnar MZ, Kovesdy CP, Kalantar-Zadeh K, Park J (2014). Mortality of combined serum phosphorus and parathyroid hormone concentrations and their changes over time in hemodialysis patients. Bone, 61, 201-7. ()
    135. Mucsi I, Ujszaszi A, Czira ME, Novak M, Molnar MZ (2013). Red cell distribution width is associated with mortality in kidney transplant recipients. Int Urol Nephrol, 46(3), 641-51. ()
    136. Vber O, Lendvai Z, Ronai KZ, Dunai A, Zoller R, Lindner AV, Turnyi CZ, Szocs JL, Keresztes K, Tabk AG, Novak M, Molnar MZ, Mucsi I (2013). Obstructive sleep apnea and heart rate variability in male patients with metabolic syndrome: cross-sectional study. Metab Syndr Relat Disord, 12(2), 117-24. ()
    137. Molnar MZ, Kalantar-Zadeh K, Lott EH, Lu JL, Malakauskas SM, Ma JZ, Quarles DL, Kovesdy CP (2013). Angiotensin-converting enzyme inhibitor, angiotensin receptor blocker use, and mortality in patients with chronic kidney disease. J Am Coll Cardiol, 63(7), 650-658. ()
    138. Molnar MZ, Foster CE 3rd, Sim JJ, Remport A, Krishnan M, Kovesdy CP, Kalantar-Zadeh K (2013). Association of pre-transplant blood pressure with post-transplant outcomes. Clin Transplant, 28(2), 166-76. ()
    139. Park J, Ahmadi SF, Streja E, Molnar MZ, Flegal KM, Gillen D, Kovesdy CP, Kalantar-Zadeh K (2013). Obesity paradox in end-stage kidney disease patients. Prog Cardiovasc Dis, 56(4), 415-25. ()
    140. Molnar MZ, Prasad GV, Yuen DA, Jothy S, Zaltzman JS (2014). A clinical and pathological variant of acute transplant glomerulopathy. Case Rep Pathol, 2014, 961987. ()
    141. Ahmadi SF, Zahmatkesh G, Streja E, Molnar MZ, Rhee CM, Kovesdy CP, Gillen DL, Steiner S, Kalantar-Zadeh K (2014). Body mass index and mortality in kidney transplant recipients: a systematic review and meta-analysis. Am J Nephrol, 40(4), 315-24. ()
    142. Rattanasompattikul M, Molnar MZ, Lee ML, Dukkipati R, Bross R, Jing J, Kim Y, Voss AC, Benner D, Feroze U, Macdougall IC, Tayek JA, Norris KC, Kopple JD, Unruh M, Kovesdy CP, Kalantar-Zadeh K (2013). Anti-Inflammatory and Anti-Oxidative Nutrition in Hypoalbuminemic Dialysis Patients (AIONID) study: results of the pilot-feasibility, double-blind, randomized, placebo-controlled trial. J Cachexia Sarcopenia Muscle, 4(4), 247-57. ()
    143. Streja E, Lau WL, Goldstein L, Sim JJ, Molnar MZ, Nissenson AR, Kovesdy CP, Kalantar-Zadeh K (2014). Hyperphosphatemia is a combined function of high serum PTH and high dietary protein intake in dialysis patients. Kidney Int Suppl (2011), 3(5), 462-468. ()
    144. Lertdumrongluk P, Rhee CM, Park J, Lau WL, Moradi H, Jing J, Molnar MZ, Brunelli SM, Nissenson AR, Kovesdy CP, Kalantar-Zadeh K (2013). Association of serum phosphorus concentration with mortality in elderly and nonelderly hemodialysis patients. J Ren Nutr, 23(6), 411-21. ()
    145. Molnar MZ, Ichii H, Lineen J, Foster CE 3rd, Mathe Z, Schiff J, Kim SJ, Pahl MV, Amin AN, Kalantar-Zadeh K, Kovesdy CP (2013). Timing of return to dialysis in patients with failing kidney transplants. Semin Dial, 26(6), 667-74. ()
    146. Hatamizadeh P, Ravel V, Lukowsky LR, Molnar MZ, Moradi H, Harley K, Pahl M, Kovesdy CP, Kalantar-Zadeh K (2013). Iron indices and survival in maintenance hemodialysis patients with and without polycystic kidney disease. Nephrol Dial Transplant, 28(11), 2889-98. ()
    147. Harley KT, Streja E, Rhee CM, Molnar MZ, Kovesdy CP, Amin AN, Kalantar-Zadeh K (2013). Nephrologist caseload and hemodialysis patient survival in an urban cohort. J Am Soc Nephrol, 24(10), 1678-87. ()
    148. Kovesdy CP, Bleyer AJ, Molnar MZ, Ma JZ, Sim JJ, Cushman WC, Quarles LD, Kalantar-Zadeh K (2013). Blood pressure and mortality in U.S. veterans with chronic kidney disease: a cohort study. Ann Intern Med, 159(4), 233-42. ()
    149. Kim Y, Park JC, Molnar MZ, Shah A, Benner D, Kovesdy CP, Kopple JD, Kalantar-Zadeh K (2012). Correlates of low hemoglobin A1c in maintenance hemodialysis patients. Int Urol Nephrol, 45(4), 1079-90. ()
    150. Kovesdy CP, Quarles LD, Lott EH, Lu JL, Ma JZ, Molnar MZ, Kalantar-Zadeh K (2013). Survival advantage in black versus white men with CKD: effect of estimated GFR and case mix. Am J Kidney Dis, 62(2), 228-35. ()
    151. Park J, Mehrotra R, Rhee CM, Molnar MZ, Lukowsky LR, Patel SS, Nissenson AR, Kopple JD, Kovesdy CP, Kalantar-Zadeh K (2013). Serum creatinine level, a surrogate of muscle mass, predicts mortality in peritoneal dialysis patients. Nephrol Dial Transplant, 28(8), 2146-55. ()
    152. Rattanasompattikul M, Molnar MZ, Zaritsky JJ, Hatamizadeh P, Jing J, Norris KC, Kovesdy CP, Kalantar-Zadeh K (2012). Association of malnutrition-inflammation complex and responsiveness to erythropoiesis-stimulating agents in long-term hemodialysis patients. Nephrol Dial Transplant, 28(7), 1936-45. ()
    153. Ravel VA, Molnar MZ, Streja E, Kim JC, Victoroff A, Jing J, Benner D, Norris KC, Kovesdy CP, Kopple JD, Kalantar-Zadeh K (2013). Low protein nitrogen appearance as a surrogate of low dietary protein intake is associated with higher all-cause mortality in maintenance hemodialysis patients. J Nutr, 143(7), 1084-92. ()
    154. Li J, Molnar MZ, Zaritsky JJ, Sim JJ, Streja E, Kovesdy CP, Salusky I, Kalantar-Zadeh K (2013). Correlates of parathyroid hormone concentration in hemodialysis patients. Nephrol Dial Transplant, 28(6), 1516-25. ()
    155. Ujszaszi A, Molnar MZ, Czira ME, Novak M, Mucsi I (2013). Renal function is independently associated with red cell distribution width in kidney transplant recipients: a potential new auxiliary parameter for the clinical evaluation of patients with chronic kidney disease. Br J Haematol, 161(5), 715-25. ()
    156. Hatamizadeh P, Molnar MZ, Streja E, Lertdumrongluk P, Krishnan M, Kovesdy CP, Kalantar-Zadeh K (2013). Recipient-related predictors of kidney transplantation outcomes in the elderly. Clin Transplant, 27(3), 436-43. ()
    157. Park J, Jin DC, Molnar MZ, Dukkipati R, Kim YL, Jing J, Levin NW, Nissenson AR, Lee JS, Kalantar-Zadeh K (2013). Mortality predictability of body size and muscle mass surrogates in Asian vs white and African American hemodialysis patients. Mayo Clin Proc, 88(5), 479-86. ()
    158. Kovesdy CP, Lott EH, Lu JL, Malakauskas SM, Ma JZ, Molnar MZ, Kalantar-Zadeh K (2012). Outcomes associated with microalbuminuria: effect modification by chronic kidney disease. J Am Coll Cardiol, 61(15), 1626-33. ()
    159. Zeb I, Ahmadi N, Molnar MZ, Li D, Shantouf R, Hatamizadeh P, Choi T, Kalantar-Zadeh K, Budoff MJ (2012). Association of coronary artery calcium score and vascular dysfunction in long-term hemodialysis patients. Hemodial Int, 17(2), 216-22. ()
    160. Hoshino J, Molnar MZ, Yamagata K, Ubara Y, Takaichi K, Kovesdy CP, Kalantar-Zadeh K (2012). Developing an HbA(1c)-based equation to estimate blood glucose in maintenance hemodialysis patients. Diabetes Care, 36(4), 922-7. ()
    161. Patel SS, Molnar MZ, Tayek JA, Ix JH, Noori N, Benner D, Heymsfield S, Kopple JD, Kovesdy CP, Kalantar-Zadeh K (2012). Serum creatinine as a marker of muscle mass in chronic kidney disease: results of a cross-sectional study and review of literature. J Cachexia Sarcopenia Muscle, 4(1), 19-29. ()
    162. Alam A, Molnar MZ, Czira ME, Rudas A, Ujszaszi A, Kalantar-Zadeh K, Rosivall L, Mucsi I (2012). Serum adiponectin levels and mortality after kidney transplantation. Clin J Am Soc Nephrol, 8(3), 460-7. ()
    163. Kim Y, Molnar MZ, Rattanasompattikul M, Hatamizadeh P, Benner D, Kopple JD, Kovesdy CP, Kalantar-Zadeh K (2012). Relative contributions of inflammation and inadequate protein intake to hypoalbuminemia in patients on maintenance hemodialysis. Int Urol Nephrol, 45(1), 215-27. ()
    164. Vashistha T, Kalantar-Zadeh K, Molnar MZ, Torln K, Mehrotra R (2012). Dialysis modality and correction of uremic metabolic acidosis: relationship with all-cause and cause-specific mortality. Clin J Am Soc Nephrol, 8(2), 254-64. ()
    165. Molnar MZ, Kovesdy CP, Bunnapradist S, Streja E, Krishnan M, Mucsi I, Norris KC, Kalantar-Zadeh K (2012). Donor race and outcomes in kidney transplant recipients. Clin Transplant, 27(1), 37-51. ()
    166. Isakova T, Xie H, Messinger S, Cortazar F, Scialla JJ, Guerra G, Contreras G, Roth D, Burke GW 3rd, Molnar MZ, Mucsi I, Wolf M (2012). Inhibitors of mTOR and risks of allograft failure and mortality in kidney transplantation. Am J Transplant, 13(1), 100-10. ()
    167. Hoshino J, Mehrotra R, Rhee CM, Yamagata K, Ubara Y, Takaichi K, Kovesdy CP, Molnar MZ, Kalantar-Zadeh K (2013). Using hemoglobin A1c to derive mean blood glucose in peritoneal dialysis patients. Am J Nephrol, 37(5), 413-20. ()
    168. Rattanasompattikul M, Feroze U, Molnar MZ, Dukkipati R, Kovesdy CP, Nissenson AR, Norris KC, Kopple JD, Kalantar-Zadeh K (2011). Charlson comorbidity score is a strong predictor of mortality in hemodialysis patients. Int Urol Nephrol, 44(6), 1813-23. ()
    169. Molnar MZ, Kovesdy CP, Mucsi I, Salusky IB, Kalantar-Zadeh K (2012). Association of pre-kidney transplant markers of mineral and bone disorder with post-transplant outcomes. Clin J Am Soc Nephrol, 7(11), 1859-71. ()
    170. Miller JE, Molnar MZ, Kovesdy CP, Zaritsky JJ, Streja E, Salusky I, Arah OA, Kalantar-Zadeh K (2012). Administered paricalcitol dose and survival in hemodialysis patients: a marginal structural model analysis. Pharmacoepidemiol Drug Saf, 21(11), 1232-9. ()
    171. Molnar MZ, Kovesdy CP, Rosivall L, Bunnapradist S, Hoshino J, Streja E, Krishnan M, Kalantar-Zadeh K (2012). Associations of pre-transplant anemia management with post-transplant delayed graft function in kidney transplant recipients. Clin Transplant, 26(5), 782-91. ()
    172. Lievense H, Kalantar-Zadeh K, Lukowsky LR, Molnar MZ, Duong U, Nissenson A, Krishnan M, Krediet R, Mehrotra R (2012). Relationship of body size and initial dialysis modality on subsequent transplantation, mortality and weight gain of ESRD patients. Nephrol Dial Transplant, 27(9), 3631-8. ()
    173. Ujszaszi A, Czira ME, Fornadi K, Novak M, Mucsi I, Molnar MZ (2012). Quality of life and protein-energy wasting in kidney transplant recipients. Int Urol Nephrol, 44(4), 1257-68. ()
    174. Molnar MZ, Bunnapradist S, Huang E, Krishnan M, Nissenson AR, Kovesdy CP, Kalantar-Zadeh K (2012). Association of pre-transplant erythropoiesis-stimulating agent responsiveness with post-transplant outcomes. Nephrol Dial Transplant, 27(8), 3345-51. ()
    175. Torln K, Kalantar-Zadeh K, Molnar MZ, Vashistha T, Mehrotra R (2012). Serum potassium and cause-specific mortality in a large peritoneal dialysis cohort. Clin J Am Soc Nephrol, 7(8), 1272-84. ()
    176. Park J, Lertdumrongluk P, Molnar MZ, Kovesdy CP, Kalantar-Zadeh K (2012). Glycemic control in diabetic dialysis patients and the burnt-out diabetes phenomenon. Curr Diab Rep, 12(4), 432-9. ()
    177. Shah A, Molnar MZ, Lukowsky LR, Zaritsky JJ, Kovesdy CP, Kalantar-Zadeh K (2012). Hemoglobin level and survival in hemodialysis patients with polycystic kidney disease and the role of administered erythropoietin. Am J Hematol, 87(8), 833-6. ()
    178. Lukowsky LR, Molnar MZ, Zaritsky JJ, Sim JJ, Mucsi I, Kovesdy CP, Kalantar-Zadeh K (2011). Mineral and bone disorders and survival in hemodialysis patients with and without polycystic kidney disease. Nephrol Dial Transplant, 27(7), 2899-907. ()
    179. Molnar MZ, Streja E, Kovesdy CP, Hoshino J, Hatamizadeh P, Glassock RJ, Ojo AO, Kalantar-Zadeh K (2012). Estimated glomerular filtration rate at reinitiation of dialysis and mortality in failed kidney transplant recipients. Nephrol Dial Transplant, 27(7), 2913-21. ()
    180. Kalantar-Zadeh K, Molnar MZ, Kovesdy CP, Mucsi I, Bunnapradist S (2012). Management of mineral and bone disorder after kidney transplantation. Curr Opin Nephrol Hypertens, 21(4), 389-403. ()
    181. Lindner A, Fornadi K, Lazar AS, Czira ME, Dunai A, Zoller R, Veber O, Szentkiralyi A, Kiss Z, Toronyi E, Mucsi I, Novak M, Molnar MZ (2011). Periodic limb movements in sleep are associated with stroke and cardiovascular risk factors in patients with renal failure. J Sleep Res, 21(3), 297-307. ()
    182. Molnar MZ, Langer RM, Remport A, Czira ME, Rajczy K, Kalantar-Zadeh K, Kovesdy CP, Novak M, Mucsi I, Rosivall L (2011). Roma ethnicity and clinical outcomes in kidney transplant recipients. Int Urol Nephrol, 44(3), 945-54. ()
    183. Molnar MZ, Streja E, Kovesdy CP, Shah A, Huang E, Bunnapradist S, Krishnan M, Kopple JD, Kalantar-Zadeh K (2012). Age and the associations of living donor and expanded criteria donor kidneys with kidney transplant outcomes. Am J Kidney Dis, 59(6), 841-8. ()
    184. Feroze U, Kalantar-Zadeh K, Sterling KA, Molnar MZ, Noori N, Benner D, Shah V, Dwivedi R, Becker K, Kovesdy CP, Raj DS (2011). Examining associations of circulating endotoxin with nutritional status, inflammation, and mortality in hemodialysis patients. J Ren Nutr, 22(3), 317-26. ()
    185. Kalantar-Zadeh K, Streja E, Molnar MZ, Lukowsky LR, Krishnan M, Kovesdy CP, Greenland S (2012). Mortality prediction by surrogates of body composition: an examination of the obesity paradox in hemodialysis patients using composite ranking score analysis. Am J Epidemiol, 175(8), 793-803. ()
    186. Fornadi K, Lindner A, Czira ME, Szentkiralyi A, Lazar AS, Zoller R, Turanyi CZ, Veber O, Novak M, Mucsi I, Molnar MZ (2011). Lack of association between objectively assessed sleep disorders and inflammatory markers among kidney transplant recipients. Int Urol Nephrol, 44(2), 607-17. ()
    187. Ricks J, Molnar MZ, Kovesdy CP, Shah A, Nissenson AR, Williams M, Kalantar-Zadeh K (2012). Glycemic control and cardiovascular mortality in hemodialysis patients with diabetes: a 6-year cohort study. Diabetes, 61(3), 708-15. ()
    188. Molnar MZ, Ojo AO, Bunnapradist S, Kovesdy CP, Kalantar-Zadeh K (2012). Timing of dialysis initiation in transplant-naive and failed transplant patients. Nat Rev Nephrol, 8(5), 284-92. ()
    189. Kovesdy CP, Lott EH, Lu JL, Malakauskas SM, Ma JZ, Molnar MZ, Kalantar-Zadeh K (2012). Hyponatremia, hypernatremia, and mortality in patients with chronic kidney disease with and without congestive heart failure. Circulation, 125(5), 677-84. ()
    190. Cortazar F, Molnar MZ, Isakova T, Czira ME, Kovesdy CP, Roth D, Mucsi I, Wolf M (2011). Clinical outcomes in kidney transplant recipients receiving long-term therapy with inhibitors of the mammalian target of rapamycin. Am J Transplant, 12(2), 379-87. ()
    191. Molnar MZ, Mehrotra R, Duong U, Bunnapradist S, Lukowsky LR, Krishnan M, Kovesdy CP, Kalantar-Zadeh K (2011). Dialysis modality and outcomes in kidney transplant recipients. Clin J Am Soc Nephrol, 7(2), 332-41. ()
    192. Duong U, Kalantar-Zadeh K, Molnar MZ, Zaritsky JJ, Teitelbaum I, Kovesdy CP, Mehrotra R (2012). Mortality associated with dose response of erythropoiesis-stimulating agents in hemodialysis versus peritoneal dialysis patients. Am J Nephrol, 35(2), 198-208. ()
    193. Molnar MZ, Tabak AG, Alam A, Czira ME, Rudas A, Ujszaszi A, Beko G, Novak M, Kalantar-Zadeh K, Kovesdy CP, Mucsi I (2011). Serum erythropoietin level and mortality in kidney transplant recipients. Clin J Am Soc Nephrol, 6(12), 2879-86. ()
    194. Molnar MZ, Huang E, Hoshino J, Krishnan M, Nissenson AR, Kovesdy CP, Kalantar-Zadeh K (2011). Association of pretransplant glycemic control with posttransplant outcomes in diabetic kidney transplant recipients. Diabetes Care, 34(12), 2536-41. ()
    195. Noori N, Caulfield MP, Salameh WA, Reitz RE, Nicholas SB, Molnar MZ, Nissenson AR, Kovesdy CP, Kalantar-Zadeh K (2011). Novel lipoprotein subfraction and size measurements in prediction of mortality in maintenance hemodialysis patients. Clin J Am Soc Nephrol, 6(12), 2861-70. ()
    196. Polner K, Szeifert L, Vmos EP, Ambrus C, Molnr MZ, Ladnyi E, Kiss I, Kiss E, Trk M, Kopp MS, Novk M, Rosivall L, Mucsi I, Tri S (2011). Psychosocial characteristics and self-reported functional status in patients on maintenance dialysis in Hungary. Clin Nephrol, 76(6), 455-63. ()
    197. Sampaio MS, Molnar MZ, Kovesdy CP, Mehrotra R, Mucsi I, Sim JJ, Krishnan M, Nissenson AR, Kalantar-Zadeh K (2011). Association of pretransplant serum phosphorus with posttransplant outcomes. Clin J Am Soc Nephrol, 6(11), 2712-21. ()
    198. Ricks J, Molnar MZ, Kovesdy CP, Kopple JD, Norris KC, Mehrotra R, Nissenson AR, Arah OA, Greenland S, Kalantar-Zadeh K (2011). Racial and ethnic differences in the association of body mass index and survival in maintenance hemodialysis patients. Am J Kidney Dis, 58(4), 574-82. ()
    199. Molnar-Varga M, Molnar MZ, Szeifert L, Kovacs AZ, Kelemen A, Becze A, Laszlo G, Szentkiralyi A, Czira ME, Mucsi I, Novak M (2011). Health-related quality of life and clinical outcomes in kidney transplant recipients. Am J Kidney Dis, 58(3), 444-52. ()
    200. Molnar MZ, Streja E, Kovesdy CP, Budoff MJ, Nissenson AR, Krishnan M, Anker SD, Norris KC, Fonarow GC, Kalantar-Zadeh K (2011). High platelet count as a link between renal cachexia and cardiovascular mortality in end-stage renal disease patients. Am J Clin Nutr, 94(3), 945-54. ()
    201. Molnar MZ, Mehrotra R, Duong U, Kovesdy CP, Kalantar-Zadeh K (2011). Association of hemoglobin and survival in peritoneal dialysis patients. Clin J Am Soc Nephrol, 6(8), 1973-81. ()
    202. Molnar MZ, Czira ME, Rudas A, Ujszaszi A, Lindner A, Fornadi K, Kiss I, Remport A, Novak M, Kennedy SH, Rosivall L, Kovesdy CP, Mucsi I (2011). Association of the malnutrition-inflammation score with clinical outcomes in kidney transplant recipients. Am J Kidney Dis, 58(1), 101-8. ()
    203. Molnar MZ, Kovesdy CP, Mucsi I, Bunnapradist S, Streja E, Krishnan M, Kalantar-Zadeh K (2011). Higher recipient body mass index is associated with post-transplant delayed kidney graft function. Kidney Int, 80(2), 218-24. ()
    204. Ambrus C, Almasi C, Berta K, Deak G, Marton A, Molnar MZ, Nemeth Z, Horvath C, Lakatos P, Szathmari M, Mucsi I (2010). Vitamin D insufficiency and bone fractures in patients on maintenance hemodialysis. Int Urol Nephrol, 43(2), 475-82. ()
    205. Molnar MZ, Czira ME, Rudas A, Ujszaszi A, Haromszeki B, Kosa JP, Lakatos P, Beko G, Sarvary E, Varga M, Fornadi K, Novak M, Rosivall L, Kiss I, Remport A, Goldsmith DJ, Kovesdy CP, Mucsi I (2010). Association between the malnutrition-inflammation score and post-transplant anaemia. Nephrol Dial Transplant, 26(6), 2000-6. ()
    206. Streja E, Kovesdy CP, Molnar MZ, Norris KC, Greenland S, Nissenson AR, Kopple JD, Kalantar-Zadeh K (2011). Role of nutritional status and inflammation in higher survival of African American and Hispanic hemodialysis patients. Am J Kidney Dis, 57(6), 883-93. ()
    207. Streja E, Molnar MZ, Kovesdy CP, Bunnapradist S, Jing J, Nissenson AR, Mucsi I, Danovitch GM, Kalantar-Zadeh K (2011). Associations of pretransplant weight and muscle mass with mortality in renal transplant recipients. Clin J Am Soc Nephrol, 6(6), 1463-73. ()
    208. Wolf M, Molnar MZ, Amaral AP, Czira ME, Rudas A, Ujszaszi A, Kiss I, Rosivall L, Kosa J, Lakatos P, Kovesdy CP, Mucsi I (2011). Elevated fibroblast growth factor 23 is a risk factor for kidney transplant loss and mortality. J Am Soc Nephrol, 22(5), 956-66. ()
    209. Molnar MZ, Kovesdy CP, Bunnapradist S, Streja E, Mehrotra R, Krishnan M, Nissenson AR, Kalantar-Zadeh K (2011). Associations of pretransplant serum albumin with post-transplant outcomes in kidney transplant recipients. Am J Transplant, 11(5), 1006-15. ()
    210. Duong U, Mehrotra R, Molnar MZ, Noori N, Kovesdy CP, Nissenson AR, Kalantar-Zadeh K (2011). Glycemic control and survival in peritoneal dialysis patients with diabetes mellitus. Clin J Am Soc Nephrol, 6(5), 1041-8. ()
    211. Feroze U, Noori N, Kovesdy CP, Molnar MZ, Martin DJ, Reina-Patton A, Benner D, Bross R, Norris KC, Kopple JD, Kalantar-Zadeh K (2011). Quality-of-life and mortality in hemodialysis patients: roles of race and nutritional status. Clin J Am Soc Nephrol, 6(5), 1100-11. ()
    212. Kelen K, Ferenczi D, Jankovics I, Varga M, Molnar MZ, Sallay P, Reusz G, Langer RM, Pasti K, Gerlei Z, Szabo AJ (2011). H1N1 vaccination in pediatric renal transplant patients. Transplant Proc, 43(4), 1244-6. ()
    213. Kovesdy CP, Mucsi I, Czira ME, Rudas A, Ujszaszi A, Rosivall L, Kim SJ, Wolf M, Molnar MZ (2011). Association of serum phosphorus level with anemia in kidney transplant recipients. Transplantation, 91(8), 875-82. ()
    214. Molnar MZ, Streja E, Kovesdy CP, Bunnapradist S, Sampaio MS, Jing J, Krishnan M, Nissenson AR, Danovitch GM, Kalantar-Zadeh K (2011). Associations of body mass index and weight loss with mortality in transplant-waitlisted maintenance hemodialysis patients. Am J Transplant, 11(4), 725-36. ()
    215. Remport A, Keszei A, Vamos EP, Novak M, Jaray J, Rosivall L, Mucsi I, Molnar MZ (2010). Association of pre-transplant dialysis duration with outcome in kidney transplant recipients: a prevalent cohort study. Int Urol Nephrol, 43(1), 215-24. ()
    216. Ambrus C, Almasi C, Berta K, Deak G, Marton A, Molnar MZ, Nemeth Z, Horvath C, Lakatos P, Szathmari M, Mucsi I (2010). Bone mineral density and parathyroid function in patients on maintenance hemodialysis. Int Urol Nephrol, 43(1), 191-201. ()
    217. Kovacs AZ, Molnar MZ, Szeifert L, Ambrus C, Molnar-Varga M, Szentkiralyi A, Mucsi I, Novak M (2010). Sleep disorders, depressive symptoms and health-related quality of life--a cross-sectional comparison between kidney transplant recipients and waitlisted patients on maintenance dialysis. Nephrol Dial Transplant, 26(3), 1058-65. ()
    218. Szentkiralyi A, Czira ME, Molnar MZ, Kovesdy CP, Remport A, Szeifert L, Vamos EP, Juhasz J, Turanyi CZ, Mucsi I, Novak M (2011). High risk of obstructive sleep apnea is a risk factor of death censored graft loss in kidney transplant recipients: an observational cohort study. Sleep Med, 12(3), 267-73. ()
    219. Czira ME, Lindner AV, Szeifert L, Molnar MZ, Fornadi K, Kelemen A, Laszlo G, Mucsi I, Keszei AP, Kennedy SH, Novak M (2010). Association between the Malnutrition-Inflammation Score and depressive symptoms in kidney transplanted patients. Gen Hosp Psychiatry, 33(2), 157-65. ()
    220. Molnar MZ, Mucsi I, Macdougall IC, Marsh JE, Yaqoob M, Main J, Courtney AE, Fogarty D, Mikhail A, Choukroun G, Short CD, Covic A, Goldsmith DJ (2010). Prevalence and management of anaemia in renal transplant recipients: data from ten European centres. Nephron Clin Pract, 117(2), c127-34. ()
    221. Kiss Z, Ambrus C, Almasi C, Berta K, Deak G, Horonyi P, Kiss I, Lakatos P, Marton A, Molnar MZ, Nemeth Z, Szabo A, Mucsi I (2010). Serum 25(OH)-cholecalciferol concentration is associated with hemoglobin level and erythropoietin resistance in patients on maintenance hemodialysis. Nephron Clin Pract, 117(4), c373-8. ()
    222. Kovesdy CP, Molnar MZ, Czira ME, Rudas A, Ujszaszi A, Sarvary E, Ambrus C, Szathmari M, Remport A, Mucsi I (2010). Diagnostic accuracy of serum parathyroid hormone levels in kidney transplant recipients with moderate-to-advanced CKD. Nephron Clin Pract, 118(2), c78-85. ()
    223. Feroze U, Molnar MZ, Dukkipati R, Kovesdy CP, Kalantar-Zadeh K (2011). Insights into nutritional and inflammatory aspects of low parathyroid hormone in dialysis patients. J Ren Nutr, 21(1), 100-4. ()
    224. Noori N, Kovesdy CP, Dukkipati R, Feroze U, Molnar MZ, Bross R, Nissenson AR, Kopple JD, Norris KC, Kalantar-Zadeh K (2011). Racial and ethnic differences in mortality of hemodialysis patients: role of dietary and nutritional status and inflammation. Am J Nephrol, 33(2), 157-67. ()
    225. Kovesdy CP, Molnar MZ, Czira ME, Rudas A, Ujszaszi A, Rosivall L, Szathmari M, Covic A, Keszei A, Beko G, Lakatos P, Kosa J, Mucsi I (2010). Associations between serum leptin level and bone turnover in kidney transplant recipients. Clin J Am Soc Nephrol, 5(12), 2297-304. ()
    226. Molnar MZ, Lukowsky LR, Streja E, Dukkipati R, Jing J, Nissenson AR, Kovesdy CP, Kalantar-Zadeh K (2010). Blood pressure and survival in long-term hemodialysis patients with and without polycystic kidney disease. J Hypertens, 28(12), 2475-84. ()
    227. Kovesdy CP, Czira ME, Rudas A, Ujszaszi A, Rosivall L, Novak M, Kalantar-Zadeh K, Molnar MZ, Mucsi I (2010). Body mass index, waist circumference and mortality in kidney transplant recipients. Am J Transplant, 10(12), 2644-51. ()
    228. Remport A, Molnar MZ, Ambrus C, Keszei A, Torok S, Vamos EP, Kiss I, Jaray J, Novak M, Rosivall L, Mucsi I (2009). Impaired renal function is associated with mortality in kidney-transplanted patients. Int Urol Nephrol, 42(3), 799-809. ()
    229. Novak M, Molnar MZ, Szeifert L, Kovacs AZ, Vamos EP, Zoller R, Keszei A, Mucsi I (2010). Depressive symptoms and mortality in patients after kidney transplantation: a prospective prevalent cohort study. Psychosom Med, 72(6), 527-34. ()
    230. Molnar MZ, Keszei A, Czira ME, Rudas A, Ujszaszi A, Haromszeki B, Kosa JP, Lakatos P, Sarvary E, Beko G, Fornadi K, Kiss I, Remport A, Novak M, Kalantar-Zadeh K, Kovesdy CP, Mucsi I (2010). Evaluation of the malnutrition-inflammation score in kidney transplant recipients. Am J Kidney Dis, 56(1), 102-11. ()
    231. Szeifert L, Molnar MZ, Ambrus C, Koczy AB, Kovacs AZ, Vamos EP, Keszei A, Mucsi I, Novak M (2009). Symptoms of depression in kidney transplant recipients: a cross-sectional study. Am J Kidney Dis, 55(1), 132-40. ()
    232. Molnar MZ, Lazar AS, Lindner A, Fornadi K, Czira ME, Dunai A, Zoller R, Szentkiralyi A, Rosivall L, Shapiro CM, Novak M, Mucsi I (2009). Sleep apnea is associated with cardiovascular risk factors among kidney transplant patients. Clin J Am Soc Nephrol, 5(1), 125-32. ()
    233. Fodor A, Molnar MZ, Krenacs L, Bagdi E, Csomor J, Matolcsy A, Demeter J (2009). Autoimmune hemolytic anemia as a risk factor of poor outcome in patients with splenic marginal zone lymphoma. Pathol Oncol Res, 15(4), 597-603. ()
    234. Ambrus C, Molnar MZ, Czira ME, Rosivall L, Kiss I, Remport A, Szathmari M, Mucsi I (2009). Calcium, phosphate and parathyroid metabolism in kidney transplanted patients. Int Urol Nephrol, 41(4), 1029-38. ()
    235. Szentkiralyi A, Molnar MZ, Czira ME, Deak G, Lindner AV, Szeifert L, Torzsa P, Vamos EP, Zoller R, Mucsi I, Novak M (2008). Association between restless legs syndrome and depression in patients with chronic kidney disease. J Psychosom Res, 67(2), 173-80. ()
    236. Vamos EP, Csepanyi G, Zambo M, Molnar MZ, Rethelyi J, Kovacs A, Marton A, Nemeth Z, Novak M, Mucsi I (2008). Sociodemographic factors and patient perceptions are associated with attitudes to kidney transplantation among haemodialysis patients. Nephrol Dial Transplant, 24(2), 653-60. ()
    237. Molnar MZ, Novak M, Mucsi I (2009). Sleep disorders and quality of life in renal transplant recipients. Int Urol Nephrol, 41(2), 373-82. ()
    238. Mucsi I, Kovacs AZ, Molnar MZ, Novak M (2008). Co-morbidity and quality of life in chronic kidney disease patients. J Nephrol, 21 Suppl 13, S84-91. ()
    239. Molnar MZ, Novak M, Szeifert L, Ambrus C, Keszei A, Koczy A, Lindner A, Barotfi S, Szentkiralyi A, Remport A, Mucsi I (2006). Restless legs syndrome, insomnia, and quality of life after renal transplantation. J Psychosom Res, 63(6), 591-7. ()
    240. Molnar MZ, Szentkiralyi A, Lindner A, Czira ME, Szeifert L, Kovacs AZ, Fornadi K, Szabo A, Rosivall L, Mucsi I, Novak M (2007). Restless legs syndrome and mortality in kidney transplant recipients. Am J Kidney Dis, 50(5), 813-20. ()
    241. Molnar MZ, Szentkiralyi A, Lindner A, Czira ME, Szabo A, Mucsi I, Novak M (2007). High prevalence of patients with a high risk for obstructive sleep apnoea syndrome after kidney transplantation--association with declining renal function. Nephrol Dial Transplant, 22(9), 2686-92. ()
    242. Molnar MZ, Czira M, Ambrus C, Szeifert L, Szentkiralyi A, Beko G, Rosivall L, Remport A, Novak M, Mucsi I (2007). Anemia is associated with mortality in kidney-transplanted patients--a prospective cohort study. Am J Transplant, 7(4), 818-24. ()
    243. Molnar MZ, Fornadi K, Shapiro CM (2006). Ropinirole treatment for restless legs syndrome. Drugs Today (Barc), 42(9), 587-98. ()
    244. Barotfi S, Molnar MZ, Almasi C, Kovacs AZ, Remport A, Szeifert L, Szentkiralyi A, Vamos E, Zoller R, Eremenco S, Novak M, Mucsi I (2005). Validation of the Kidney Disease Quality of Life-Short Form questionnaire in kidney transplant patients. J Psychosom Res, 60(5), 495-504. ()
    245. Novak M, Molnar MZ, Ambrus C, Kovacs AZ, Koczy A, Remport A, Szeifert L, Szentkiralyi A, Shapiro CM, Kopp MS, Mucsi I (2005). Chronic insomnia in kidney transplant recipients. Am J Kidney Dis, 47(4), 655-65. ()
    246. Molnar MZ, Novak M, Mucsi I (2006). Management of restless legs syndrome in patients on dialysis. Drugs, 66(5), 607-24. ()
    247. Molnar MZ, Novak M, Ambrus C, Kovacs A, Pap J, Remport A, Szeifert L, Mucsi I (2005). Anemia in kidney transplanted patients. Clin Transplant, 19(6), 825-33. ()
    248. Mucsi I, Molnar MZ, Ambrus C, Szeifert L, Kovacs AZ, Zoller R, Bartfi S, Remport A, Novak M (2005). Restless legs syndrome, insomnia and quality of life in patients on maintenance dialysis. Nephrol Dial Transplant, 20(3), 571-7. ()
    249. Molnar MZ, Novak M, Ambrus C, Szeifert L, Kovacs A, Pap J, Remport A, Mucsi I (2005). Restless Legs Syndrome in patients after renal transplantation. Am J Kidney Dis, 45(2), 388-96. ()
    250. Novak M, Mah K, Molnar MZ, Ambrus C, Csepanyi G, Kovacs A, Vamos E, Zambo M, Zoller R, Mucsi I, Devins GM (2003). Factor structure and reliability of the Hungarian version of the Illness Intrusiveness Scale: invariance across North American and Hungarian dialysis patients. J Psychosom Res, 58(1), 103-10. ()
    251. Mucsi I, Molnar MZ, Rethelyi J, Vamos E, Csepanyi G, Tompa G, Barotfi S, Marton A, Novak M (2004). Sleep disorders and illness intrusiveness in patients on chronic dialysis. Nephrol Dial Transplant, 19(7), 1815-22. ()

    Review

    1. Tantisattamo E, Kalantar-Zadeh K, Molnar MZ (2021). Nutritional and dietary interventions to prolong renal allograft survival after kidney transplantation. [Review]. Curr Opin Nephrol Hypertens, 31(1), 6-17. ()
    2. Lubetzky M, Tantisattamo E, Molnar MZ, Lentine KL, Basu A, Parsons RF, Woodside KJ, Pavlakis M, Blosser CD, Singh N, Concepcion BP, Adey D, Gupta G, Faravardeh A, Kraus E, Ong S, Riella LV, Friedewald J, Wiseman A, Aala A, Dadhania DM, Alhamad T (2021). The failing kidney allograft: A review and recommendations for the care and management of a complex group of patients. [Review]. Am J Transplant, 21(9), 2937-2949. ()

    Editorial

    1. Saran R, Robinson B, Abbott KC, Agodoa LYC, Bragg-Gresham J, Balkrishnan R, Bhave N, Dietrich X, Ding Z, Eggers PW, Gaipov A, Gillen D, Gipson D, Gu H, Guro P, Haggerty D, Han Y, He K, Herman W, Heung M, Hirth RA, Hsiung JT, Hutton D, Inoue A, Jacobsen SJ, Jin Y, Kalantar-Zadeh K, Kapke A, Kleine CE, Kovesdy CP, Krueter W, Kurtz V, Li Y, Liu S, Marroquin MV, McCullough K, Molnar MZ, Modi Z, Montez-Rath M, Moradi H, Morgenstern H, Mukhopadhyay P, Nallamothu B, Nguyen DV, Norris KC, OHare AM, Obi Y, Park C, Pearson J, Pisoni R, Potukuchi PK, Repeck K, Rhee CM, Schaubel DE, Schrager J, Selewski DT, Shamraj R, Shaw SF, Shi JM, Shieu M, Sim JJ, Soohoo M, Steffick D, Streja E, Sumida K, Kurella Tamura M, Tilea A, Turf M, Wang D, Weng W, Woodside KJ, Wyncott A, Xiang J, Xin X, Yin M, You AS, Zhang X, Zhou H, Shahinian V (2019). US Renal Data System 2018 Annual Data Report: Epidemiology of Kidney Disease in the United States. Am J Kidney Dis, 73(3 Suppl 1), A7-A8. ()
    2. Saran R, Robinson B, Abbott KC, Agodoa LYC, Bhave N, Bragg-Gresham J, Balkrishnan R, Dietrich X, Eckard A, Eggers PW, Gaipov A, Gillen D, Gipson D, Hailpern SM, Hall YN, Han Y, He K, Herman W, Heung M, Hirth RA, Hutton D, Jacobsen SJ, Jin Y, Kalantar-Zadeh K, Kapke A, Kovesdy CP, Lavallee D, Leslie J, McCullough K, Modi Z, Molnar MZ, Montez-Rath M, Moradi H, Morgenstern H, Mukhopadhyay P, Nallamothu B, Nguyen DV, Norris KC, OHare AM, Obi Y, Park C, Pearson J, Pisoni R, Potukuchi PK, Rao P, Repeck K, Rhee CM, Schrager J, Schaubel DE, Selewski DT, Shaw SF, Shi JM, Shieu M, Sim JJ, Soohoo M, Steffick D, Streja E, Sumida K, Tamura MK, Tilea A, Tong L, Wang D, Wang M, Woodside KJ, Xin X, Yin M, You AS, Zhou H, Shahinian V (2018). US Renal Data System 2017 Annual Data Report: Epidemiology of Kidney Disease in the United States. Am J Kidney Dis, 71(3 Suppl 1), A7. ()
    3. Saran R, Robinson B, Abbott KC, Agodoa LY, Albertus P, Ayanian J, Balkrishnan R, Bragg-Gresham J, Cao J, Chen JL, Cope E, Dharmarajan S, Dietrich X, Eckard A, Eggers PW, Gaber C, Gillen D, Gipson D, Gu H, Hailpern SM, Hall YN, Han Y, He K, Hebert H, Helmuth M, Herman W, Heung M, Hutton D, Jacobsen SJ, Ji N, Jin Y, Kalantar-Zadeh K, Kapke A, Katz R, Kovesdy CP, Kurtz V, Lavalee D, Li Y, Lu Y, McCullough K, Molnar MZ, Montez-Rath M, Morgenstern H, Mu Q, Mukhopadhyay P, Nallamothu B, Nguyen DV, Norris KC, OHare AM, Obi Y, Pearson J, Pisoni R, Plattner B, Port FK, Potukuchi P, Rao P, Ratkowiak K, Ravel V, Ray D, Rhee CM, Schaubel DE, Selewski DT, Shaw S, Shi J, Shieu M, Sim JJ, Song P, Soohoo M, Steffick D, Streja E, Tamura MK, Tentori F, Tilea A, Tong L, Turf M, Wang D, Wang M, Woodside K, Wyncott A, Xin X, Zang W, Zepel L, Zhang S, Zho H, Hirth RA, Shahinian V (2017). US Renal Data System 2016 Annual Data Report: Epidemiology of Kidney Disease in the United States. Am J Kidney Dis, 69(3 Suppl 1), A7-A8. ()
    4. Saran R, Li Y, Robinson B, Abbott KC, Agodoa LY, Ayanian J, Bragg-Gresham J, Balkrishnan R, Chen JL, Cope E, Eggers PW, Gillen D, Gipson D, Hailpern SM, Hall YN, He K, Herman W, Heung M, Hirth RA, Hutton D, Jacobsen SJ, Kalantar-Zadeh K, Kovesdy CP, Lu Y, Molnar MZ, Morgenstern H, Nallamothu B, Nguyen DV, OHare AM, Plattner B, Pisoni R, Port FK, Rao P, Rhee CM, Sakhuja A, Schaubel DE, Selewski DT, Shahinian V, Sim JJ, Song P, Streja E, Kurella Tamura M, Tentori F, White S, Woodside K, Hirth RA (2016). US Renal Data System 2015 Annual Data Report: Epidemiology of Kidney Disease in the United States. Am J Kidney Dis, 67(3 Suppl 1), Svii, S1-305. ()
    5. Saran R, Li Y, Robinson B, Ayanian J, Balkrishnan R, Bragg-Gresham J, Chen JT, Cope E, Gipson D, He K, Herman W, Heung M, Hirth RA, Jacobsen SS, Kalantar-Zadeh K, Kovesdy CP, Leichtman AB, Lu Y, Molnar MZ, Morgenstern H, Nallamothu B, OHare AM, Pisoni R, Plattner B, Port FK, Rao P, Rhee CM, Schaubel DE, Selewski DT, Shahinian V, Sim JJ, Song P, Streja E, Kurella Tamura M, Tentori F, Eggers PW, Agodoa LY, Abbott KC (2015). US Renal Data System 2014 Annual Data Report: Epidemiology of Kidney Disease in the United States. Am J Kidney Dis, 66(1 Suppl 1), Svii, S1-305. ()
    6. Kovesdy CP, Molnar MZ (2014). Restricting kidney transplant wait-listing for obese patients: let's stop defending the indefensible. Semin Dial, 27(1), 1-3. ()
    7. Shah A, Molnar MZ, Kalantar-Zadeh K (2011). It is not polite to ask a dialysis patient his age! Int Urol Nephrol, 43(4), 1101-5. ()

    Letter

    1. Azhar A, Kleiboeker S, Khorsandi S, Duncan Kilpatrick M, Khan A, Gungor A, Molnar MZ, Morales M, Levy M, Kamal L, Moinuddin I, Kumar D, Tanriover B, Gupta G (2022). Detection of Transmissible Severe Acute Respiratory Syndrome Coronavirus-2 From Deceased Kidney Donors: Implications for Kidney Transplant Recipients. [Letter to the editor]. Transplantation, 107(2), e65-e67. ()
    2. Gupta G, Azhar A, Gungor A, Molnar MZ, Morales MK, Tanriover B (2022). Early Data on Utilization and Discard of Organs From COVID-19-infected Donors: A US National Registry Analysis. [Letter to the editor]. Transplantation, 106(5), e266-e268. ()
    3. Molnar MZ, Hall IE, Raghavan D, Shihab F, Imlay H, Hanson KE, Gomez CA, Campsen J, Kim R, Baker N, Rofaiel G (2021). Kidney transplantation from SARS-CoV-2-positive deceased donor. [Letter to the editor]. Am J Transplant, 22(4), 1280-1282. ()
    4. Ali H, Mohamed M, Molnar MZ, Krishnan N (2021). Is it safe to receive kidneys from deceased kidney donors tested positive for covid-19 infection? [Letter to the editor]. Ren Fail, 43(1), 1060-1062. ()
    5. Tsujita M, Azhar A, Joglekar K, Talwar M, Balaraman V, Bhalla A, Eason JD, Molnar MZ (2021). The incidence of hepatitis B coinfection after deceased-donor kidney transplantation from hepatitis C infected donors to hepatitis C negative recipients. [Letter to the editor]. Transpl Int, 34(5), 986-987. ()
    6. Molnar MZ, Kovesdy CP, Kalantar-Zadeh K (2017). The Authors' Reply. [Letter to the editor]. Transplantation, 102(2), e87. ()
    7. Gosmanova EO, Molnar MZ, Kovesdy CP (2016). Reply: Systolic Blood Pressure Variability: Is Obstructive Sleep Apnea a Bigger Factor at Play? [Letter to the editor]. J Am Coll Cardiol, 69(7), 908-909. ()
    8. Kovesdy CP, Norris KC, Boulware LE, Lu JL, Ma JZ, Streja E, Molnar MZ, Kalantar-Zadeh K (2016). Response to Letter Regarding Article, "Association of Race With Mortality and Cardiovascular Events in a Large Cohort of US Veterans". [Letter to the editor]. Circulation, 133(12), e453. ()
    9. Streja E, Molnar MZ, Kovesdy CP (2011). Race, age, and mortality among patients undergoing dialysis. [Letter to the editor]. JAMA, 306(20), 2215; author reply 2215-6. ()